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PREFACE - SPECIFIC AIMS 
Sleep apnea is characterized by a decline in breathing stability, leading to a decrease or 
complete cessation of airflow during sleep. The occurrence of adverse breathing events tends to 
be cyclical, the severity of which is affected by alterations in chemoreflex properties and upper 
airway collapsibility. The accompanying intermittent hypoxia and sleep fragmentation associated 
with breathing events has been linked to many cardiovascular, cognitive and metabolic disorders. 
Published studies indicate that the severity of breathing events is modulated by an endogenous 
circadian rhythm; since the duration and number has been reported to increase from the evening 
to the morning, while computer simulations predicted a decrease in such events during daytime 
compared to nighttime sleep.  
Aim 1 is designed to confirm that the severity of breathing events during sleep is affected 
by the time of day. Aim 1 will also investigate if alterations in chemoreflex properties and upper 
airway collapsibility are responsible for the alterations in breathing events across the 24 hour 
cycle. We hypothesize that the duration and number of breathing events will be greater during 
sleep in the morning compared to the afternoon and evening. We also postulate that the critical 
closing pressure (i.e. a measure of upper airway collapsibility) and chemoreflex sensitivity will 
increase, while the carbon dioxide reserve will decrease in the morning compared to the 
afternoon and evening. 
If breathing stability and the mechanisms that affect this stability are altered by the time 
of day this could impact on therapeutic treatments for obstructive sleep apnea.  For example, 
continuous positive airway pressure, which is used to treat sleep apnea, could be reduced at 
certain times of the day/night if those mechanisms that influence upper airway collapsibility are 
affected. Likewise, if other concurrent mechanisms that promote breathing stability are affected 
by the time of day this could lead to the development of adjunct therapies that could be used 
 v 
independently or alongside continuous positive airway pressure to more effectively eliminate 
breathing events. We, and other investigators, have shown that an increase in upper airway 
muscle activity is initiated in response to intermittent hypoxia. Increases in upper airway muscle 
activity would likely promote stability and contribute to decreasing the severity of apneic events. 
Aim 2 will investigate whether the therapeutic continuous positive airway pressure 
required to eliminate breathing events varies across the 24 hour cycle. We hypothesize that this 
pressure will be highest in the morning as a result of the heightened breathing instability and 
lowest during sleep in the afternoon and early evening where the mechanisms promoting 
instability are mitigated. In addition, Aim 2 will examine if initiation of respiratory plasticity, 
namely long-term facilitation of upper airway muscle activity, following exposure to intermittent 
hypoxia impacts the therapeutic pressure and is affected by the time of day. We hypothesize that 
long-term facilitation of upper-airway muscle activity will be promoted in the evening and 
afternoon in line with the alterations in the aforementioned mechanisms that enhance breathing 
stability, and mitigated in the morning where breathing is less stable. 
Our findings could provide the rationale for careful determination of therapeutic pressure 
during sleep over the day/night cycle. Our results will also establish if other potential novel 
adjunct therapies (i.e. intermittent hypoxia) might serve to improve the treatment of sleep apnea. 
Lastly, our findings will provide the rationale for altering the administered dose of treatments at 
that have recently been proposed to treat sleep apnea at specific time points. 
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CHAPTER 1 - INTRODUCTION 
Sleep disordered breathing 
Sleep serves an important function in many species, including humans; from 
physiological maintenance of cells, to memory consolidation and other cognitive functions.  
However sleep poses a challenge for the respiratory system.  During wakefulness the level of 
carbon dioxide and the consequent intracellular pH are the principal stimuli for ventilation (Fink, 
1961); however other neural mechanisms also contribute to the maintenance of ventilation 
(Longobardo et al., 2002).  Environmental factors, including audio and visual stimuli, as well as 
mental activity, modulate breathing independent of changes in blood gas levels and 
chemoreceptor feedback (Fink, 1961; Shea et al., 1987; Nielsen and Smith, 1952; Mohan and 
Duffin, 1997).  In contrast, during sleep, breathing is controlled primarily by the carotid body 
and central chemoreceptors located in the ventral region of the brainstem.  Changes in blood 
gases levels detected by these chemoreceptors induce appropriate changes in ventilation to 
preserve normal levels (Mateika and Syed, 2013).  In addition to the absence of the wakefulness 
drive, the activity of upper airway dilator muscles decreases at sleep onset, rendering a narrower 
airway with a greater tendency to collapse and create airflow obstruction.  
Apnea during sleep is defined by the complete cessation of breathing for a period of at 
least 10 seconds.  Both apneas and hypopneas (i.e. partial reductions in ventilation) lead to a 
decrease in oxygen and an increase in carbon dioxide levels in the blood.  The cessation of 
airflow can be due to collapse of the upper airway, which is defined as an obstructive apnea, or 
the cessation of respiratory motor output from the brainstem, which is characteristic of a central 
apnea.  An apnea can also be of mixed nature, which includes a central and obstructive 
component (Dempsey et al., 2010).  Risk factors for sleep disordered breathing include body 
weight, gender, age, and craniofacial structure.  Untreated sleep apnea/hypopnea increases the 
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risk of fatal and non-fatal cardiovascular events (Marin et al., 2005, Dempsey et al, 2010).  
Moreover, disorders linked to insulin resistance and altered neurobehavioral function could be 
directly or indirectly linked to sleep apnea; since recurrent exposure to hypoxia, hypercapnia and 
sleep disruptions affects many systems and cellular processes (Dempsey et al., 2010).  These 
processes include activation of pro-inflammatory pathways, increases in reactive oxygen species, 
and disruptions in hormonal levels (e.g. leptin and ghrelin).  Consequently, obstructive sleep 
apnea likely plays a role in the initiation and perpetuation of many disorders.  
Mechanisms affecting the severity of sleep disordered breathing 
Apneic events tend to occur in a cyclical fashion (Figure 1).  At the onset of sleep the 
upper airway collapses, leading to an apneic event and subsequent changes in blood gas levels.   
The origins of upper airway collapse are two-fold.  Isono et al. (1997) observed that the upper 
Figure 1. Schematic diagram showing the sequence of events leading to the development of a
central and/or obstructive apnea, and subsequent events that ultimately results in re-establishing
patency of the upper airway. (Mateika and Syed, 2013) 
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airway was more collapsible in sleep apnea patients compared to controls in the presence of 
complete neuromuscular blockade, which suggests that tissue properties have a role in upper 
airway collapsibility.  In addition, it was observed in both animal and human models that upper 
airway collapsibility is increased during anesthesia or sleep in response to reductions in 
neuromuscular activity (Brouillette et al.1979; Seelagy et al. 1994; Patil et al. 2007 and 
McGinley et al. 2008).  Younes et al. (2003) suggested that one third of apneic events can be 
attributed to structural alterations and defects, while the remainder is attributed to neuromuscular 
deficits.  
Independent of the mechanism, apneic events are usually accompanied by arousal from 
sleep which restores airway patency.  However, arousal is often associated with increases in 
ventilation, which are meant to restore normal blood gases levels, but often exceed metabolic 
rate leading to hypocapnia.  While such a decrease is not necessarily problematic in the wake 
state, it is during sleep.  If carbon dioxide decreases below a set point deemed "the apneic 
threshold”, a central apnea will occur once sleep is re-established.  In addition, the decrease in 
carbon dioxide is accompanied by a reduction in upper airway neuromuscular compensation, 
since carbon dioxide is an essential stimulus in the modulation of upper airway muscle activity 
via the hypoglossal nerve.  The cycle then repeats itself multiple times throughout the night 
(Mateika and Syed, 2013).  
The severity of this cyclical pattern depends upon multiple mechanisms, including, but 
not exclusive to, upper airway collapsibility and properties of the chemoreflex response to 
changes in blood gases.  As seen in Figure 1, reduced neuromuscular compensation will decrease 
upper airway patency and promote the occurrence of an apnea.  In addition, heightened 
chemoreceptor sensitivity, to decreases in oxygen and increases in carbon dioxide levels that 
occur during breathing events, promotes exaggerated levels of ventilation upon arousal which 
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increases apneic severity by inducing hypocapnia.  Reductions in the carbon dioxide reserve (i.e. 
the difference between the carbon dioxide baseline level and the apneic threshold), whether a 
consequence of changes in chemoreflex sensitivity, the apneic threshold or baseline carbon 
dioxide, promote hypocapnia.  
Time of day affects breathing mechanisms 
Circadian effect on breathing instability.  In addition to apneic events occurring in a 
cyclical fashion, the severity of these events, characterized by an increase in number and 
duration of events, appears to be affected by the time of day.  A number of studies have shown 
that breathing events increase in number (Fanfulla et al. 1997) and duration (Cala et al, .1996; 
Sforza et al., 1998) during sleep from the beginning to the end of the night independent of sleep 
stage.  In addition, computer modeling simulations have predicted a reduction in the number of 
breathing events during daytime compared to nighttime sleep (Stephenson et al., 2004).  If the 
results of these small clinical studies are correct then fluctuations in chemoreflex properties (i.e. 
chemoreflex sensitivity and a reduction in the carbon dioxide reserve) and mechanisms that 
influence upper airway collapsibility across the 24 hour cycle could be responsible for the 
reported increases in breathing instability.   
This suggestion is supported by the results obtained by Sforza et al. (1998) who showed 
that an increase in the duration of breathing events during the night was accompanied by an 
increase in respiratory drive, which could be a consequence of enhanced chemoreflex sensitivity.   
In addition to these findings, Mahamed et al. (2005) measured chemoreflex sensitivity during 
wakefulness before and after 6 hours of sleep in individuals with sleep apnea and reported an 
increase in the morning compared to the evening.  Therefore, increases in chemoreflex 
sensitivity are evident from the evening to the morning in individuals with sleep apnea.  
However, these increases may not be a consequence of time of day per se but rather a 
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consequence of confounding factors that are linked to sleep apnea, including intermittent 
hypoxia.  Indeed, numerous studies have shown that chemoreflex sensitivity increases following 
exposure to intermittent hypoxia in both healthy individuals and individuals with sleep apnea.  
However, to our knowledge no studies have been designed to determine if alterations in 
chemoreflex properties are affected by time of day independent of other confounding factors 
associated with sleep apnea.  Our preliminary results (see Figure 4 in Chapter 2) suggest that this 
is the case, since the carbon dioxide reserve was reduced and chemoreflex sensitivity was 
increased in the morning compared to the evening and afternoon, independent of other 
confounding factors, in a group of sleep apnea participants that completed a constant routine 
protocol.  Therefore, Aim 1 of my prospectus is designed in part to confirm that the severity of 
sleep apnea is affected by the time of day.  Likewise, aim 1 is designed to determine if 
chemoreflex properties are affected by the time of day independent of confounding factors that 
normally are linked to breathing instability during sleep.  
Moreover, time of day might also affect upper airway muscle function.  This suggestion is 
supported indirectly from studies (Martin et al. 1999 and Zhang et al. 2009) which reported that 
the force and strength of limb muscles are greater in the late afternoon compared to the early 
morning, which could be indicative of a circadian rhythm to the control of muscle activity.  This 
possibility is supported by studies which have shown that serotonin (Agren et al., 1986, Mateos 
et al., 2009 and Sun et al., 2002), brain derived neurotrophic factor (BDNF) and phosphorylated 
extracellular regulated kinases (Serchov and Heumann, 2006), which all have a role in 
modulating hypoglossal motor neuron activity, are regulated by a circadian rhythm.  In addition, 
5-HT2A receptor mRNA levels in rats differ between two time points, being higher at the onset of 
the active phase (6–7 pm) compared to the onset of the rest period (8–9 am) (Volgin et al. 2013).  
To my knowledge, no studies have examined the variation in upper airway collapsibility across 
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the 24 cycle.  However, our preliminary data (see Figure 6 in Chapter 2) indicates that the active 
critical closing pressure of the upper airway, which is an indicator of the neuromuscular 
contribution to maintaining airway patency, is more positive (i.e. more collapsible) in the 
morning compared to the evening and afternoon.   
Therefore, Aim 1 will also examine if passive tissue and neuromuscular properties that 
influence airway patency is affected by the time of day in individuals with sleep apnea. 
Collectively, we hypothesize that the severity of apneic events will be greater in the morning 
compared to the afternoon and evening.  Moreover, we hypothesize that chemoreflex sensitivity 
will be greater, the carbon dioxide reserve will be reduced and the airway will be more 
collapsible in the morning compared to the afternoon or evening sleep.  
Respiratory plasticity 
Increases or decreases in neuronal activity can strengthen or weaken connections as well 
as activating de novo and/or pre-existing neuronal pathways that have been quiescent.  This 
phenomenon is often referred to as synaptic plasticity.  Forms of synaptic plasticity include 
respiratory long-term facilitation which is characterized by a progressive increase in respiratory 
motor output during normoxic periods after exposure to intermittent hypoxia, and progressive 
augmentation which is characterized by enhancement of the hypoxic ventilatory response 
(Mateika and Syed, 2013).  
Long-term facilitation is initiated by intermittent but not sustained hypoxia (Figure 2).  
Single hypoxic episodes that are brief can lead to acute increases in respiratory motor output that 
return to baseline levels within minutes following the hypoxic episode.  However,  successive 
episodes (i.e. intermittent hypoxia) lead to sustained respiratory motor output for up to 90 
minutes following the final hypoxic episode (Figure 2) (Baker and Mitchell, 2000; Mitchell et 
al., 2001).   
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This phenomenon is governed by cellular mechanisms that respond differently to changes 
in the intensity of administered hypoxia.  Exposure to moderate acute intermittent hypoxia leads 
to the release of serotonin at the level of spinal respiratory motoneurons.  The binding of 
serotonin to 5-HT2 receptors leads to production of brain derived neurotrophic factor, activation 
of TrkB receptor and ERK-MAPK signaling that results in facilitation of the input to the 
respiratory motor neuron (Figure 3a).  Also contributing to this pathway is the production of 
reactive oxygen species by NADPH oxidase which inhibits protein phosphatases and leads to 
activation of PKC and production of BDNF.  This pathway is referred to as the Q pathway since 
it involves activation of the Gq protein coupled to the 5-HT2 receptor.  In response to exposure to 
severe intermittent hypoxia (Figure 3a), there is accumulation of extracellular adenosine which 
activates adenosine 2A receptors and consequently TrkB and Akt, with eventual facilitation of 
the motor input.  This pathway is deemed the S pathway since it involves activation of the the Gs 
protein coupled to the adenosine 2A receptor.  Under conditions of severe hypoxia the S pathway 
may exert an inhibitory effect on the Q pathway thereby dominating the control of the response. 
This cross talk between the 2 pathways allows for great flexibility in the system and the ability to 
express different forms of plasticity in response to different conditions. 
Figure 2. Integrated 
phrenic discharge in one
rat exposed to episodic
hypoxia and one rat
exposed to 20 min
continuous hypoxia.
Integrated phrenic
discharge during baseline,
hypoxia, and 15, 30 and 60
min post-hypoxia. Note 
that only intermittent
hypoxia elicited LTF. 
(Baker and Mitchell, 2000) 
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Long-term facilitation of ventilation and genioglossus muscle activity have been 
documented in healthy humans and humans with obstructive sleep apnea during both 
wakefulness and sleep.  We have shown in our laboratory that this phenomenon is exquisitely 
dependent on carbon dioxide levels.  In other words, long-term facilitation manifests itself when 
carbon dioxide is sustained slightly above baseline levels but is not evident when carbon dioxide 
levels are not controlled and hypocapnia ensues.  The presence of this phenomenon in humans is 
exciting because it may ultimately lead to the development of adjunctive therapies to treat 
obstructive sleep apnea.   
Presently, the most common treatment for sleep apnea is continuous positive airway 
pressure.  The positive pressure serves as a splint to maintain airway patency, thereby relieving 
Figure 3a.  Cellular pathways involved in
phrenic motor long term facilitation
following acute intermittent hypoxia. (A)
The Gq protein–coupled 5-HT2 receptor is
activated leading to PKC activation and
synthesis of brain derived neurotrophic
factor. The activation of TrkB by BDNF
phosphorylates ERK, thereby facilitating
input to the motor neuron. (B) The Gs
protein–coupled adenosine 2A (A2A)
receptor is activated, leading to a cascade
of PKA, TrkB and Akt activation. The
result is the facilitation of respiratory
motoneuron input. (DeVinney et al., 2013) 
 
 
9 
 
 
airflow obstruction.  However, there are multiple side effects associated with this treatment 
modality that has resulted in limited compliance.  The lack of compliance in some cases may be 
a consequence of elevated levels of positive pressure that are required to maintain airway 
patency.  Thus, adjunctive therapies that contribute to reducing the effective positive airway 
pressure may ultimately lead to improved compliance.  Recognition that stability of the upper 
airway is influenced by the time of day (see above Specific Aim 1) may lead to careful 
determination of therapeutic positive pressure values during sleep at different times across the 24 
hour cycle.  Moreover, if long-term facilitation of genioglossus muscle activity can be initiated in 
individuals with sleep apnea this phenomenon may serve to reduce the effective therapeutic 
pressure to treat sleep apnea at a given point in the 24 hour cycle.  More interestingly, if this 
form of respiratory plasticity is affected by the time of day, its influence may be more effective 
at certain points throughout the day/night cycle.   
As a result, Aim 2 is designed to determine if the continuous positive airway pressure 
required to eliminate breathing events varies across the 24 hour cycle, hence significantly 
impacting the therapeutic approach to the treatment of sleep apnea.  Aim 2 will also determine if 
long-term facilitation of upper airway muscle activity influence levels of therapeutic positive 
airway pressure and whether this influence is variable and dependent on the time of day.  
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CHAPTER 2 - TIME OF DAY AFFECTS THE FREQUENCY AND  
DURATION OF BREATHING EVENTS AND THE CRITICAL CLOSING  
PRESSURE DURING NREM SLEEP IN PARTICIPANTS WITH SLEEP APNEA  
(This chapter contains previously published material. See Appendix B) 
Introduction 
Clinical studies have reported that independent of sleep stage and body position, the 
number (Fanfulla et al., 1997;Sforza et al., 1998) and duration (Cala et al., 1996;Charbonneau et 
al., 1994;Lavie et al., 1981;Montserrat et al., 1996a;Sforza et al., 1998) of breathing events 
increase throughout the night during non-rapid eye movement sleep; although to our knowledge 
no studies have examined if these differences manifest in a similar manner in stages N1 and N2 
of non-rapid eye movement sleep.  Likewise, computer simulations have suggested that a 
reduction in the apnea-hypopnea index during daytime compared to nighttime sleep may occur 
(Stephenson, 2004).  This latter postulation has been reported in a small number of hypertensive 
men, although other confounding factors may have influenced the findings (Scharf et al., 1990). 
The potential mechanisms underlying the increase in the number and duration of 
breathing events across a 24-hr period are likely multifactorial and phenotypically dependent.  
One possibility is that increases in chemoreflex sensitivity, coupled to a reduction in the carbon 
dioxide reserve contribute to the progressive increase in breathing events across the night (see 
Chapter 3 for the detailed findings) (El-Chami et al., 2014a;Mateika & Narwani, 2009;Mateika 
& Sandhu, 2011;Mateika & Syed, 2013a;Mateika, 2015;Mateika et al., 2015).  This possibility is 
well founded in that enhanced chemoreflex sensitivity promotes the occurrence of both central 
and obstructive breathing events (Dempsey et al., 2004;Dempsey, 2005;Dempsey et al., 
2010;Yokhana et al., 2012).  The results from many studies indicate that the increase in 
chemoreflex sensitivity across the night could be the result of exposure to intermittent hypoxia, a 
hallmark of sleep apnea (Chowdhuri et al., 2010;Gerst, III et al., 2011;Griffin et al., 
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2012;Khodadadeh et al., 2006;Mateika et al., 2004a;Wadhwa et al., 2008).  However, we 
showed that increases in chemoreflex sensitivity and decreases in the carbon dioxide reserve 
were evident during sleep in the morning compared to the evening and afternoon; independent of 
physiological hallmarks typically associated with sleep apnea (i.e. intermittent hypoxia and sleep 
fragmentation) (El-Chami et al., 2014a).      
Previous studies have also addressed if increases in the arousal threshold or effective 
recruitment threshold of upper airway muscles are responsible for reported increases in apnea 
duration from the beginning to the end of the night.  Based on a series of studies, a number of 
investigators (Berry et al., 1995;Cala et al., 1996;Montserrat et al., 1996a) proposed that 
inflammation, edema, neural damage in response to snoring related vibrations, and forceful 
collapse of the larynx progressively dampen excitatory inputs from upper airway sensory 
receptors from the beginning to the end of the night, leading to alterations in the arousal and/or 
effective recruitment threshold.  Thus, the effect of time of day on the arousal and/or effective 
recruitment threshold was linked to factors that are a consequence of apnea and not 
endogenously modulated by a circadian rhythm.  Traumatization of the upper airway could also 
account for increases in frequency of apnea events since collapsibility of the upper airway could 
be impacted by upper airway muscle fatigue associated with exposure to intermittent hypoxia 
(Bradford et al., 2005;McGuire et al., 2002;Ray et al., 2007) and dampening of excitatory 
sensory inputs from the upper airway receptors (Cala et al., 1996).   
Despite these findings, we were interested in determining if alterations in upper airway 
collapsibility occur in accordance with the time of day, independent of deleterious factors 
typically associated with sleep apnea.  To our knowledge no studies have directly examined the 
effect of time of day on upper airway muscle collapsibility in humans with sleep apnea.  
Nevertheless, existing evidence indicates that upper airway collapsibility, via modulation of 
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neuromuscular properties, could be affected by the time of day.  Many studies in humans [see 
(Zhang et al., 2009) for review] have shown that force, along with other measures of muscle 
function [i.e. rate of tension development and one-half relaxation time (Martin et al., 1999)], in 
skeletal muscle ranging from the abductor pollicus (Martin et al., 1999) to leg extensor muscles 
(Sedliak et al., 2008), are enhanced in the late afternoon and evening compared to the early 
morning.  In addition, studies in other animals have reported that the concentration of a 
neuromodulator involved in the control of upper airway muscle activity (i.e. serotonin) along 
with receptor sub-types (i.e. 5HT2A) are modulated by the time of day (Agren et al., 1986;Mateos 
et al., 2009;Sun et al., 2002;Volgin et al., 2013).    
Therefore, the primary aims of the present investigation were two-fold.  First, we 
examined the effect of time of day on the duration and frequency of breathing events during non-
rapid eye movement sleep in the evening, morning and afternoon in individuals with sleep apnea 
using a constant routine protocol.  This aim was completed to confirm the results from previous 
clinical studies and to add to these findings by exploring the characteristics of breathing events 
during N1 and N2 sleep at three time periods throughout the 24 hour cycle.  We hypothesized 
that the duration and frequency of breathing events would be greater during sleep in the morning 
compared to the evening and afternoon.  The second aim of the study was to examine if 
collapsibility of the upper airway, via measures of the critical closing pressure, was altered when 
these measures were compared during non-rapid eye movement sleep in the evening, morning 
and afternoon.  We hypothesized that the critical closing pressure would be more positive in the 
morning compared to the evening and afternoon, if the modulation of upper airway muscle 
function is similar to that reported previously for other skeletal muscles.   
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Methods 
Protocol 
The Human Investigation Committees of Wayne State University School of Medicine 
and John D. Dingell Veterans Affairs Medical Center approved the experimental protocol.  
Thirteen male participants with untreated pure or predominantly obstructive sleep apnea, but no 
other comorbidities (e.g., heart and lung disease, hypertension, and obesity), completed the 
protocol.  All the participants who completed the protocol visited the laboratory on six occasions 
(Figure 3).  During the first visit to the laboratory, written informed consent was obtained and 
thereafter a physical examination, health and lifestyle questionnaires, blood pressure, lung 
volume measures, and a 12-lead ECG were completed.  After ensuring that the inclusion criteria 
were met, participants completed a baseline nocturnal polysomnogram to confirm the presence 
of obstructive sleep apnea (visit 2).  Upon verification, participants were enrolled in the protocol 
and their sleep was monitored at home for 2 weeks, using an actigraph watch (Actiwatch 
Spectrum, Philips Respironics, Murraysville, PA), before obtaining the planned physiological 
Figure 3. A schematic diagram showing the protocol completed by the participants. * - 8 of 13 
participants completed visit 7. 
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measurements on visits 4–6 (see subsequent paragraph for further details).  During the two week 
time period we requested that the participants adhere to a regular sleep-wake schedule with a 
sleep onset time between 10–11 pm and a wake time of 7–8 am.  We also requested that the 
participants avoid daytime napping.  During this time period the participants returned to the 
laboratory (i.e. Visit 3) to determine the therapeutic continuous positive airway pressure required 
to maintain airway patency.  In addition, a “practice trial” using the methodology and procedures 
required to determine the critical closing pressure was completed so that each participant was 
accustomed to the procedures. 
After the 2 week time period, participants returned to the laboratory on three separate 
occasions (i.e., visits 4 –6).  Each visit was separated by a minimum of seven days.  Participants 
maintained a regular sleep-wake schedule, which was monitored with the actigraph watch, and 
were not treated with continuous positive airway pressure during the seven day interval that 
separated each visit.  Participants were asked to abstain from alcohol and caffeinated beverages 
at least one day prior to the visit.  On the day of each study, participants arrived at the laboratory 
at approximately 8:00 PM.  Upon arrival, the participants ingested a radiotelemetry pellet 
(CorTemp Sensor, Palmetto, FL) which measured core body temperature every 10 s throughout 
each visit.  This measure was used to establish the nadir of core body temperature.  Following 
instrumentation, the participants completed a constant routine protocol.  The protocol was 
comprised of sleep sessions in the evening, morning and afternoon that were 3 hours in duration 
(i.e., 10 PM – 1 AM, 6 – 9 AM, and 2 – 5 PM).  Subsequent to the evening and morning sleep 
sessions, participants were placed in a semi-recumbent position during wakefulness.  At the 
onset of each wake session, participants watched a movie for ∼ 120 min and immediately 
thereafter read for ∼ 90 min.  Ninety minutes before the morning or afternoon sleep session, the 
participants sat quietly and did not engage in any activity.  During each wake session, 
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participants received small snacks every 95 min composed of ∼ 15% fat, 75% carbohydrate, and 
10% protein.  Moreover, participants received up to a maximum of 1 liter of water over the 
length of the constant routine protocol.  During wakefulness, the participants were in a dimly lit 
(i.e., 30 lux) laboratory that was separated from sunlight and external cues including phones, 
clocks, radios, and television.  The laboratory temperature was controlled at 22–23°C. 
Interventions and procedures 
During the 4th visit, breathing events (i.e. apneas and hypopneas) were measured during 
each sleep session.  Measures of breathing events were obtained from 12 of 13 participants.  One 
participant expressed a desire to withdraw from the study because of time constraints.  
Consequently, we chose to obtain measures of the critical closing pressure (Figure 4) rather than 
measures of breathing events, prior to withdrawal.  On the 5th and 6th visits, which were 
randomized, chemoreflex properties (i.e., chemoreflex threshold, sensitivity and the carbon 
dioxide reserve) or the upper airway critical closing pressure was measured during each sleep 
session in 10 participants.  A description of the methods used to measure the chemoreflex 
properties, and the results which demonstrated the effect of time of day on these properties can 
be found in Chapter 3, in addition to being published previously (El-Chami et al., 2014a).  
Subsequent to this publication, 3 additional participants were enrolled, so that measures of the 
critical closing pressure were obtained from thirteen participants.   
In order to assess upper airway collapsibility, the critical closing pressure (i.e., the 
pressure associated with collapse of the upper airway) was measured during each sleep session 
(Figure 4). During each session, airway patency was initially maintained using a holding 
pressure that was 1.7 ± 0.5 cmH2O less than the therapeutic pressure determined during visit 3.  
The holding pressure generated a reduction in airflow of 10–15% and was employed to prevent 
over-distension of the airway.  Measurement of the critical closing pressure was performed by 
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reducing the mask pressure in a stepwise fashion, by increments of 1-2 cmH2O (Pcrit 3000, 
version 1.0, Philips Respironics, Murrysville, PA) for a duration of 3 to 5 breaths.  Each step 
down in pressure was separated by a 1 minute recovery period at the holding pressure.  Stepwise 
reductions in pressure continued until the airway was fully collapsed, which was defined by 
measures of airflow less than 10% percent of baseline.    
 
 
We were also interested in determining if measures of the critical closing pressure were 
similar at a given time of day using a well-established method (McGinley et al., 2008a) 
characterized by consecutive 1-2 cmH2O reductions in mask pressure, which were sustained for a 
duration of 5 minutes and were not separated by a recovery period at the holding pressure.  We 
rationalized that establishing a holding pressure prior to a step-down in mask pressure lasting 3-5 
breaths would be accompanied by upper airway muscle activity.  Moreover, we considered that 
reductions in airway pressure are detected in a short period of time and result in the activation of 
Figure 4. An illustration of the data collection procedures used to determine the critical closing
pressure that demarcated collapse of the upper airway. Continuous positive airway pressure was
decreased in a step wise fashion. The duration of each step was 3 to 5 breaths and was separated
by the return to a holding pressure for 1 minute.  Step wise decreases were administered until
flow was abolished (i.e. apnea) and the corresponding pressure was ascertained. 
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the upper airway muscles within 50 ms (Horner et al., 1991;Horner et al., 1994).  Consequently, 
we hypothesized that independent of the length of time maintained after a step down in pressure 
the critical closing pressure that demarcated collapse of the airway would be similar.  If 
supported, our findings would provide a rationale for using the method with step downs in 
pressure of short duration, because the overall time required to implement the methodology 
would be shorter and decrease the probability of disrupting sleep architecture.  In order to 
compare the two methods used to measure the critical closing pressure, 8 of the 13 participants 
returned to the laboratory for an additional visit (Figure 3 – visit 7).  During this visit we 
measured the critical closing pressure during sleep in the evening, morning and afternoon using 
the method characterized by step downs in mask pressure which were sustained for 5 minutes 
(McGinley et al., 2008a). 
Instrumentation 
During the sleep studies the monitoring montage included an electroencephalogram 
(C3/A2, C4/A1, O1/A2, O2/A1), electrooculograms, submental electromyogram, and an 
electrocardiogram.  Chest wall and abdominal movements were measured using inductive 
plethysmography (Respitrace, Ambulatory Monitoring, Ardsley, NY).  Airflow and breath 
timing (inspiratory and expiratory time) were measured using a pneumotachometer (model 
RSS100-HR, Hans Rudolph, Shawnee, KS) attached to a nasal mask.  Oxygen saturation (arterial 
O2 saturation) was measured with a pulse oximeter (Biox 3700; Ohmeda, Boulder, CO).  
Measures of end-tidal oxygen (Model 17515, Vacumed, Ventura, CA) and end-tidal carbon 
dioxide (Model 17518, Vacumed, Ventura, CA) were obtained from air expired into sampling 
tubes attached to ports on the nasal mask.  Mask pressure was measured using a pressure 
transducer attached via tubing to a port on the nasal mask.  Upper airway pressure was measured 
using a transducer tipped catheter (Mikro-Cath 825-0101, Millar, Houston, TX) to confirm apnea 
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and ascertain the presence of flow limitation.  All physiological variables were analog to 
digitally converted at a sampling frequency of 100 Hz/channel and input into a computer using a 
commercially available software package (gamma version 4.0, Astro-Med, West Warwick, RI).  
The cardiorespiratory variables were also input into a second computer using a commercially 
available software package (WinDaq, Dataq Instruments, Akron, OH). 
Data analysis 
All polysomnography studies were analyzed for sleep stage, arousals, and respiratory-
related events according to standard published criteria (Iber C et al., 2007).  An event 
characterized by the absence of inspiratory airflow for a minimum of 10 s was identified as an 
apnea.  A hypopnea was defined as an event accompanied by a > 50% reduction in airflow that 
lasted for a minimum of 10 s and was also accompanied by either an arousal or a ≥ 3% reduction 
in oxygen saturation in the absence of an arousal.  During the 4th visit, the number and duration 
of apneas and hypopneas, as well as, the decrease in oxygen saturation during each event were 
determined for N1 and N2 of non-rapid eye movement sleep for each sleep session.  Analyses of 
events recorded in N3 were not included in the results because the overall time spent in N3 was 
not sufficient to make adequate comparisons between sleep sessions within or across participants 
(see Table 2).  
For each participant, baseline measures of minute ventilation and the partial pressure of 
end-tidal carbon dioxide were obtained initially from a 2 minute period of stable non-rapid eye 
movement sleep prior to completing the protocol on visit 5 or 6.  Baseline measures for 10 of the 
13 participants were published previously (El-Chami et al., 2014a).  To obtain measures of the 
critical closing pressure in 13 participants, baseline values of airflow and mask pressure were 
determined initially using the last 5 breaths measured at the holding pressure prior to the initial 
step down (Figure 4).  Thereafter, with every reduction in pressure the resultant peak flow was 
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determined from the second or third breath. The breath selected displayed the greatest limitation 
in airflow (Figure 4).  In order to obtain the critical closing pressure using the method that 
incorporated pressure step-downs of longer duration (n = 8 participants), breath by breath 
measures of airflow recorded from the last 2 minutes of the baseline holding period were 
analyzed.  Thereafter, flow was measured from breaths recorded during the final 2 minutes of 
each pressure step down to determine the critical closing pressure.  If participants aroused from 
sleep prior to determining the critical closing pressure during this visit, this measure was 
extrapolated using a second-order polynomial regression from the available pressure steps 
recorded prior to arousal.  All measures of the critical closing pressure were obtained during 
stable N2 of non-rapid eye movement sleep. 
We were interested in determining the correlation between the critical closing pressure 
and baseline measures of the apnea/hypopnea index.  To examine this relationship we averaged 
the critical closing pressures measured in the evening, morning and afternoon.  In addition, to 
determine the correlation between the partial pressure of end-tidal carbon dioxide and the critical 
closing pressure we averaged values of end-tidal carbon dioxide, and averaged the critical 
closing pressure, measured in the evening, morning and afternoon.  To further explore this 
relationship, we also averaged end-tidal carbon dioxide and critical closing pressure values in the 
evening and afternoon, since measures of the critical closing pressure were similar for these two 
sessions.  Subsequently, the change in end-tidal carbon dioxide and critical closing pressure in 
the morning compared to the average of the evening/afternoon was determined in order to 
correlate these measures.   
Measurements of core body temperature were purified to eliminate small fluctuations in 
temperature associated with movements during wakefulness that occurred during feeding or 
bathroom breaks.  Thereafter, the temperature was fit with a cosine wave: 
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[y = m + a cos (2πt/ω) + ϕ] 
where y is the temperature, m is the circadian rhythm adjusted mean (i.e., mesor), a is the 
amplitude of the circadian rhythm, t is time (hours), ω is the period of the circadian rhythm, and 
ϕ is the phase angle.  Once the phase and period of the core body temperature were established 
for an individual, this information was used to assign a circadian phase (from 0 to 359°) to each 
minute, with 0° corresponding to the minimum of the waveform fitted to the core body 
temperature data.  The plotted data were then used to determine the session that corresponded to 
the core body temperature nadir. 
Statistical analysis 
A one-way repeated-measures analysis of variance in conjunction with Fisher’s least 
square difference post hoc test was used to compare sleep efficiency measures in the evening, 
morning and afternoon.  A similar analysis was used to compare the measures of the critical 
closing pressure (n = 13) and baseline measures of carbon dioxide in the evening, morning and 
afternoon.  A Kruskal-Wallis one way analysis of variance on ranks combined with Student-
Newman-Keuls post hoc test was used to compare event duration in participants that experienced 
either an increase or a decrease in event frequency during N2.  A similar analysis was used to 
compare the partial pressure of end-tidal carbon dioxide in the evening, morning and afternoon.  
A two-way repeated measures analysis of variance in conjunction with Fisher’s least square 
difference post hoc test was used to compare the percentage of time spent in N1 and N2 of non-
rapid eye movement sleep during the evening, morning, and afternoon sleep sessions.  The two 
factors in the analysis were sleep stage (i.e. N1 and N2) and time of day (i.e. evening, morning 
and afternoon).  A similar analysis was used to compare measures of breathing event duration, 
apnea/hypopnea indices, decreases in oxygen saturation and the critical closing pressure 
measured using two separate methods.  For each variable, the factors used in the analysis were 
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sleep stage and time of day, with the exception of the statistical analysis of the critical closing 
pressure.  In this case, the factors were time of day and method (i.e. brief or prolonged step-
downs in pressure) used to determine the critical closing pressure.  A Pearson correlation 
analysis was used to determine if i) the critical closing pressure was correlated to the baseline 
apnea/hypopnea index ii) the average baseline measures of end-tidal carbon dioxide were 
correlated to the average critical closing pressure measured during the evening, morning and 
afternoon; iii) the change in the partial pressure of end-tidal carbon dioxide was correlated to the 
change in the critical closing pressure from the morning to the evening and afternoon.  Data are 
presented as means ± S.E.  A P value ≤ 0.05 was considered statistically significant. 
Results 
Table 1 shows the anthropometric variables obtained for the group.  Collectively, the 
participants were young to middle age, and not obese, as indicated by the body mass index.  The 
apnea/hypopnea index determined from the screening sleep study (i.e. Visit 2) ranged from mild 
to severe according to standard criteria.  The level of oxygen desaturation achieved during 
apneic/hypopneic events was mild even in those participants considered to have severe sleep 
apnea.  Systolic and diastolic blood pressure measurements were within normal limits and the 
Epworth  sleepiness  scale   indicated   a  history  of  mild  sleepiness  (Table  1).   The   average 
Table 1. Baseline anthropometric, blood pressure and sleep measures  
Variable  
Age, yr. 29.5 ± 1.9 
Height, cm 174.5 ± 4.0 
Weight, kg 82.6 ± 2.7 
Body mass index, kg/m2 26.4 ± 0.6 
Systolic pressure, mmHg 119.2 ± 2.6 
Diastolic pressure, mmHg 72.7 ± 2.8 
Epworth Sleepiness Scale 10.0 ± 1.0 
Apnea/hypopnea index, events/hr 41.8 ± 4.7 
Lowest oxygen desaturation during apnea, % 87.2 ± 1.2 
Race 7 AA, 4 Caucasian, 1 Asian, 1 Indian 
Values are means ± SE  
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therapeutic pressure required to eliminate apnea during sleep on visit 3 in the OSA participants 
was 11.2 ± 0.8 cmH2O.  Average measures of core body temperature, recorded during visit 4 of 
the protocol, are shown in Figure 5. The nadir of temperature was evident in the early morning 
during visit 4 (Figure 5) and in the course of the visit used to measure the critical closing 
pressure.   
 
 
During visit 4, the participants spent 73.4 ± 4.9 %, 78.0 ± 2.7 % and 71.4 ± 3.6 %, of the 
total session time (i.e. 3 hours) in N1 and N2 of non-rapid eye movement sleep in the evening, 
morning and afternoon , respectively (P ≥ 0.47).  The percentage of time spent in N1 or N2 for a 
given 3-hour sleep session was not significantly different between the evening, morning and 
afternoon (Table 2) (P ≥ 0.85).  Figure 6A shows the average duration of breathing events during 
Figure 5. Average values of core body temperature in 12 participants with sleep apnea shown in
30 minute increments over a 24 hour cycle. Note that the nadir in temperature occurred at 6 am
and the peak at 7:30 pm. Zero time represents the onset of the temperature recording (9:00 p.m.). 
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Table 2. Time spent in a given stage of sleep as a percentage of session time   
 Evening Morning Afternoon 
Wake (%) 24.7 ± 5.1 9.3 ± 2.3 19.9 ± 3.8 
N1 (%) 22.7 ± 3.7 19.2 ± 2.8 20.3 ± 2.5 
N2 (%) 47.6 ± 3.4 53.0 ± 4.0 49.0 ± 3.7 
N3 (%) 3.1 ± 1.6 5.8 ± 2.5 2.1 ± 1.1 
REM (%) 1.9 ± 0.9 12.6 ± 2.9 8.7 ± 2.8 
Values are means ± SE. REM – Rapid Eye Movement Sleep. 
N1 and N2 of non-rapid eye movement sleep during the sleep sessions completed on visit 4.  The 
duration of breathing events was greater in the morning compared to the afternoon and evening 
in N1 and N2 of non-rapid eye movement sleep (P  0.001).  In addition, the duration of 
breathing events was greater during N2 compared to N1 in the evening, morning and afternoon 
(P  0.001).   
 
Figure 6. Histograms which show the
mean values for (A) the duration of
breathing events (B) the apnea hypopnea
index and (C) the decrease in oxygen
saturation, for N1 and N2 of non-rapid eye 
movement sleep in the evening, morning
and afternoon sleep sessions.  Note that
breathing event frequency was greater in
the morning compared to the afternoon
and evening in N1 and the duration of
breathing events was greater in the
morning in both N1 and N2. Also note that
the decrease in oxygen saturation was 
similar and independent of breathing event
duration. (*) significantly different from
the evening and afternoon. (‡)
significantly different from N1. 
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The apnea/hypopnea index was greater in the morning compared to the evening (P  
0.01) and afternoon (P  0.02) in N1 of non-rapid eye movement sleep (Figure 6B).  In contrast, 
the apnea/hypopnea index during the evening, morning and afternoon were similar across the 3 
sleep sessions in N2 (Figure 6B).  Further examination of the data revealed that an increase in 
event frequency was evident in 6 participants, while a decrease was evident in the remaining 
participants, in the morning compared to evening.  The decrease in event frequency was coupled 
to a longer event duration compared to the values associated with increases in event frequency 
(30.3 ± 2.8 vs. 22.8 ± 3.3 s; P  0.04). 
The apnea/hypopnea index measured during N2 was greater compared to N1 during the 
evening (P  0.02) and afternoon sleep sessions (P  0.04).  This difference was not evident 
throughout the morning sleep session.  Baseline oxygen saturation measures were similar across 
sleep sessions in N1 (evening – 98 ± 0.3 %; morning – 99 ± 0.2 % and afternoon – 99 ± 0.2 %) 
and N2 (evening – 98 ± 0.3 %; morning – 98 ± 0.2 % and afternoon – 98 ± 0.3 %).  In addition, 
the decrease in oxygen saturation during breathing events was similar in the morning compared 
to the afternoon and evening in N1 and N2 (Figure 6C).  The decrease in oxygen saturation 
during breathing events in N2 was significantly greater compared to N1 independent of the time 
of day (P  0.002). 
The critical closing pressure using brief step-downs in pressure (i.e. 3-5 breaths) was 
more positive in the morning compared to the evening (p  0.02) and afternoon (P  0.01) (n=13) 
(Figure 7A).  These relationships were unchanged (P  0.001) when the critical closing pressure 
was determined using pressure step-downs of longer duration (n=8) (Figure 7B – right side).  No 
difference in the critical closing pressure was evident in the evening, morning or afternoon when 
measures obtained from 8 participants using pressure step-downs of short (3 breaths) and long (5 
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minutes) duration were compared (Figure 7B).  The average critical closing pressure was 
correlated to the baseline apnea/hypopnea index (r = 0.60, p  0.03; r = 0.74, p  0.01 with one 
outlier removed – see Figure 8A for additional details). 
 
As previously reported for 10 of the 13 participants, baseline measures of the partial 
pressure of end-tidal carbon dioxide were lowest in the morning compared to the evening and 
afternoon (El-Chami et al., 2014a).  This relationship remained unchanged with data from 3 
additional participants included (evening 41.4 ± 0.6 vs. morning 40.2 ± 0.4 vs. afternoon 40.6 ± 
0.5 mmHg; P  0.01).  Interestingly, average baseline measures of the partial pressure of end-
Figure 7. Histograms which
show the mean critical closing
pressure in the evening, morning
and afternoon measured using
(A) brief step-downs in pressure
for 3-5 breaths (n=13) and (B)
step-downs in pressure lasting 3-
5 breaths and 5 minutes (n=8).
Note that independent of the
duration of each step-down in
pressure, the critical closing
pressure that demarcated the
upper airway collapsibility was
greater in the morning compared
to the evening and afternoon.
(*) – significantly different from
the evening and afternoon.
PCRIT – critical closing
pressure. 
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tidal carbon dioxide were correlated to the average of the critical closing pressure obtained from 
the 3 sleep sessions (r = - 0.59, P  0.04).  The highest baseline levels of PETCO2 were coupled to 
a less positive or negative critical closing pressure and vice versa.  In addition, the change in 
carbon dioxide in the morning, relative to the average value measured in the evening and 
afternoon, were strongly correlated to the change in critical closing pressure in the morning (r = - 
0.73, P  0.005) (Figure 8B).  The greater the decrease in baseline partial pressure of carbon 
dioxide the greater the increase in the critical closing pressure and vice versa.     
 
Discussion 
In the present investigation we employed a constant routine protocol to measure the 
characteristics of breathing events on one occasion, and the critical closing pressure on another, 
Figure 8. (A) A scatterplot which
shows the relationship between the
average critical closing pressure,
measured in the morning, evening
and afternoon for each participant,
and the baseline apnea/hypopnea
index. Note that the open circle
represents a value that was
significantly outside of the 99 %
confidence intervals shown on the
plot. (B) A scatterplot which shows
the correlation between the change
in carbon dioxide in the morning
compared to measures in the
evening and afternoon, and the
change in the critical closing
pressure in the morning compared
to values measured in the evening
and afternoon. 
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during non-rapid eye movement sleep in the evening, morning and afternoon in participants with 
sleep apnea.  Our primary findings revealed that the duration of breathing events increased 
during N1 and N2 of non-rapid eye movement sleep in the morning compared to the evening and 
afternoon.  Additionally, an increase in the frequency of breathing events was evident during N1 
in the morning.  Our results also showed that the critical closing pressure of the upper airway 
was more positive in the morning compared to the evening and afternoon.  Secondarily, we also 
showed that the duration and frequency of breathing events was greater in N2 compared to N1, 
and that measures of the critical closing pressure were independent of the duration of the 
reduction in pressure used to obtain these measures. 
Methodology 
Our participants did not suffer from other comorbid conditions (i.e., diabetes, 
cardiovascular disease, and obesity).  Thus, the potential influence of these comorbidities on the 
critical closing pressure was controlled.  On the other hand, our results may not be representative 
of the responses of older, obese patients who suffer from comorbid conditions.  Accordingly, the 
effect of time of day on the critical closing pressure could vary and be dependent on age and the 
presence of co-morbidities.  In addition, our study was limited to investigating the effect of time 
of day on the critical closing pressure in men. Inclusion in the study was not limited to this sex; 
rather it was by happenstance that the participants available to complete the protocol, which was 
extensive and required a number of visits to the laboratory, were male.  Consequently, future 
studies are necessary to determine whether the effect of time of day on chemoreflex properties is 
sex dependent.  
The critical closing pressure is determined by both neuromuscular and non-
neuromuscular properties.  Non-neuromuscular properties and neuromuscular properties that 
influence upper airway collapsibility may be separated if the airway is studied under conditions 
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of hypo and hypertonia, respectively (McGinley et al., 2008a;Schwartz et al., 1998).  However, 
we chose not to perform our measures under separate conditions because we were concerned that 
measures of the critical closing pressure under both conditions would not be possible in some 
participants given the duration of our sleep sessions.  Thus, to ensure that the upper airway 
muscles were active, prior to completing brief step-downs in pressure, we maintained a holding 
pressure that was 1-2 cmH2O below the therapeutic pressure.  This reduction in pressure was 
accompanied by a flow reduction of 10-15 %.   Thereafter, a negative pressure, relative to the 
holding pressure, was rapidly applied.  Based on published studies we speculate that each brief 
step-down in pressure activated the negative pressure reflex within a short time period [i.e. 50 ms 
(Horner et al., 1991;Horner et al., 1994)] resulting in a neuromuscular response that was affected 
by the time of day.  To support our contention we subsequently measured the critical closing 
pressure using step-downs of longer duration, during which time neuromuscular responses were 
undoubtedly influenced by the interaction between mechanoreceptors and chemoreceptors 
(McGinley et al., 2008a).  We surmised that if the critical closing pressure using the brief step-
downs in pressure was principally a reflection of non-neuromuscular influences on the upper 
airway, contrary to our postulation, then the critical closing measurements would be more 
positive compared to the critical closing pressure measurements attained using the prolonged 
step-downs in pressure.  This was not the case, since measures of the critical closing pressure 
were similar and independent of the method used.  Our findings suggest that the presentation of 
additional stimuli which accompany prolonged step-downs in pressure might interact in a 
complex fashion to produce a critical closing pressure similar to that induced by a brief negative 
pressure pulse.  Alternatively, the similar measures could indicate a reduced upper airway 
neuromuscular responsiveness to added stimuli that accompany prolonged step-downs in 
pressure in individuals with sleep apnea.  This possibility has been reported previously 
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(McGinley et al., 2008b).   
Arousal state effects on breathing event characteristics 
A secondary finding from our investigation was that the frequency and duration of 
breathing events was greater during N2 compared to N1.  These results are contrary to 
Ratnavadivel and colleagues (Ratnavadivel et al., 2009) findings, which showed that the 
frequency of breathing events was reduced in N2 compared to N1.  Ratnavadivel and colleagues 
(Ratnavadivel et al., 2009) did not report the duration of breathing events and the corresponding 
decrease in oxygen saturation.  It is possible that breathing event duration increased accompanied 
by greater reductions in oxygen saturation in N2 compared to N1, which is more in line with our 
results.  On the other hand, the discrepancy between our results and previous findings could be a 
reflection of the quality of N2 sleep and the level of arousal following re-establishment of airway 
patency.  Transitions from N1 to N2 sleep in individuals with sleep apnea are typically 
characterized by continued promotion of apneic events, while the transition from N2 to N3 is 
often linked to improved upper airway stability and decreases in event frequency (Eckert & 
Younes, 2014a).  Although direct comparisons of sleep depth in N2 between studies is not 
possible, it is interesting to note that participants spent approximately 22 % of non-rapid eye 
movement sleep in slow wave sleep in Ratnavadivel and colleagues investigation (Ratnavadivel 
et al., 2009) while participants in our study spent little time in N3 (see Table 2).    
Time of day effects on breathing event characteristics and upper airway collapsibility 
Published findings have reported that the frequency and/or duration of breathing events 
increases during the second compared to the first half of the night, independent of sleep stage 
(Cala et al., 1996;Charbonneau et al., 1994;Fanfulla et al., 1997;Lavie et al., 1981;Montserrat et 
al., 1996a;Sforza et al., 1998).  We have extended these findings by showing that the increase in 
the frequency and duration of breathing events during sleep in the morning are not only elevated 
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compared to measures obtained during sleep in the evening, but also compared to sleep in the 
afternoon.  In previous studies, measures obtained during non-rapid eye movement sleep were 
separated from rapid eye movement sleep to explore the time of day effect on event frequency 
and duration independent of sleep stage (Cala et al., 1996;Charbonneau et al., 1994;Lavie et al., 
1981; Montserrat et al., 1996a;Sforza et al., 1998).  Although the potential confounding 
influence of rapid eye movement sleep was controlled, the various stages of non-rapid eye 
movement sleep were presumably combined in some investigations, since controls for non-rapid 
eye movement sleep stage were undefined (Charbonneau et al., 1994;Fanfulla et al., 1997;Sforza 
et al., 1998).  Consequently, increases in event frequency or duration during the second 
compared to the initial half of the night could have been a reflection of alterations in the 
contribution of N1, N2 and N3 to non-rapid eye movement sleep.  Other studies limited analyses 
to N2 of non-rapid eye movement sleep (Cala et al., 1996;Lavie et al., 1981;Montserrat et al., 
1996a).  Thus, time of day effects on breathing event characteristics could potentially be specific 
to N2 of non-rapid eye movement sleep.  In the present investigation we explored if the effect of 
time of day on frequency and duration of events differs between N1 and N2.  Our results showed 
that the frequency of events increased in the morning compared to the evening and afternoon in 
N1 but not in N2.  Alternatively, the duration of breathing events increased in the morning 
compared to the evening and afternoon independent of the stage of non-rapid eye movement 
sleep.   
If all conditions, with the exception of event duration, remained constant for a given sleep 
session one would anticipate that the decrease in oxygen saturation would be greater during 
prolonged events.  This was not the case, since the decrease in oxygen saturation was similar 
across sleep sessions within N1 and N2.  Consequently, a longer time interval was required to 
attain a similar decrease in oxygen saturation.  It is likely that the degree of oxygen desaturation 
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was similar across sleep sessions because of differences in metabolic rate during sleep in the 
morning compared to the afternoon and evening.  Indeed, we recently reported that baseline 
measures of minute ventilation, the partial pressure of end-tidal carbon dioxide and core body 
temperature measured from 10 of the 13 participants in the present investigation, was 
significantly less in the morning compared to the evening and afternoon (El-Chami et al., 
2014a).  The addition of 3 participants did not alter this finding. 
In support of the effect that time of day has on breathing event frequency and duration, 
we also showed that the critical closing pressure that demarcates upper airway collapsibility was 
greater in the morning compared to the evening and afternoon.  Our study did not directly 
address if an inherent modulation of tissue properties or upper airway neuromuscular function 
was responsible for the increase in critical closing pressure in the morning.  However, to our 
knowledge, there is little evidence to suggest that time of day effects on tissue properties were 
responsible for our results.  On the other hand, there is substantial indirect evidence to suggest 
that endogenous modulation of upper airway neuromuscular function could have contributed to 
the effect of time of day on the critical closing pressure.  Several studies have shown that skeletal 
muscle torque, strength and power are higher in the late afternoon compared to the morning [see 
(Zhang et al., 2009) for review].  These results have been obtained in a variety of muscles 
ranging from the adductor pollicis (Martin et al., 1999) to leg extensor muscles (Sedliak et al., 
2008).  Likewise, a decrease in the rate of tension development and one-half relaxation time has 
been reported in the morning compared to the evening and afternoon (Martin et al., 1999).  
Mechanisms responsible for the circadian modulation of upper airway collapsibility 
There are multiple inputs and stimuli (Figure 9) presented on a nightly basis that could 
potentially be responsible for increases in the critical closing pressure from the evening to the 
morning, in individuals with sleep apnea.   However,  in the present study the elimination of 
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sleep apnea with continuous positive airway pressure, combined with the employed experimental 
controls (i.e. maintenance of a supine position, similar sleep state), makes it unlikely that the 
time of day effect on the critical closing pressure was a consequence of  i) blunted feedback from 
upper airway receptors  in response to inflammation, edema and/or neural damage (Cala et al., 
1996) or ii) enhanced chemoreceptor feedback in response to intermittent hypoxia (Mateika & 
Narwani, 2009;Mateika & Syed, 2013a;Mateika et al., 2015;Syed et al., 2013;Yokhana et al., 
2012).  On the other hand, indirect evidence from animal studies indicate that endogenous 
modulation of upper airway motor neurons could be responsible for the increase in the critical 
closing pressure in the morning compared to the afternoon and evening.  Serotonin, which is a 
neuromodulator of hypoglossal motor neuron activity, varies in a diurnal pattern (Agren et al., 
1986;Mateos et al., 2009;Sun et al., 2002).  Likewise, Volgin and colleagues (Volgin et al., 
2013) showed that the endogenous excitatory drive to hypoglossal motor neurons may be altered 
through circadian mechanisms in part because of variations in the availability of 5-HT2A 
receptors, which was quantified at the mRNA and protein level. 
The manner in which serotonin ultimately modulates hypoglossal or other upper airway 
motor neurons is unknown but one possibility could be linked to changes in metabolic rate, and 
more specifically to the modulation of carbon dioxide.  Synaptic connections from serotoninergic 
neurons in the raphe pallidus and obscurus project to hypoglossal motor neurons (Manaker & 
Tischler, 1993).  These serotoninergic neurons sense carbon dioxide levels (Richerson, 2004), 
which increase genioglossus muscle activity in healthy humans during wakefulness (Onal et al., 
1981;Patrick et al., 1982), and healthy humans (McSharry et al., 2013;Saboisky et al., 2010a) or 
humans with obstructive sleep apnea (Loewen et al., 2011a) during non-rapid eye movement 
sleep.  Thus, fluctuations in carbon dioxide via the modulation of raphe neurons could ultimately 
modulate upper airway muscle activity and collapsibility.  Recently, we found that minute 
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ventilation was reduced in the morning compared to the evening and afternoon coincident with 
the nadir in core body temperature and PETCO2 (El-Chami et al., 2014a).  Coincident reductions 
in PETCO2 and temperature were also noted in the morning in the present investigation.  More 
importantly, decreases in the baseline partial pressures of carbon dioxide in the morning relative 
to the afternoon and evening were correlated to increases in the critical closing pressure, in 
support of the postulated role that carbon dioxide has in modulating upper airway collapsibility.   
In addition to modulation of metabolic rate, circadian modulation of chemoreflex 
properties (Figure 9) could also elicit fluctuations in carbon dioxide that promote increased upper  
            
 
Figure 9. A schematic diagram showing a variety of inputs that impact on upper airway
collapsibility. Note that a number of stimuli (e.g. intermittent hypoxia, upper airway vibration
etc.) that progressively increase throughout the night as a consequence of sleep apnea activate a
variety of afferents that affect upper airway motor neuron and muscle activity. These inputs
could account for time of day effects on the duration and frequency of breathing events.
However, note that an endogenous circadian modulation of upper airway collapsibility, which
may be mediated by direct inputs to upper airway motor neurons and indirectly via adjustments
in chemoreflex sensitivity, occur despite the elimination of sleep apnea.   
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airway collapsibility, and ultimately alterations in breathing event frequency and/or duration.  
We recently discovered, using the experimental design employed in the present investigation, 
that chemoreflex sensitivity and the carbon dioxide reserve (i.e. the difference between the 
carbon dioxide that demarcates the point at which breathing is abolished and resting baseline 
levels of carbon dioxide) increased and decreased, respectively, during sleep in the morning 
compared to the evening and afternoon (El-Chami et al., 2014a).  In the presence of cyclic 
breathing events, increases in chemoreflex sensitivity and decreases in the carbon dioxide 
reserve could elicit profound hypocapnia and disfacilitation of upper airway motoneurons, 
increasing the propensity for upper airway collapse in the morning compared to the afternoon 
and evening.  Likewise, given that the response to hypoxia is blunted or absent in the presence of 
hypocapnia (Rapanos & Duffin, 1997a;Wilson & Day, 2013a;Moore et al., 1984;Weil et al., 
1970a), it is possible that hypoxia does not significantly enhance receptor feedback prior to the 
abolition of hypocapnia, despite enhanced chemoreflex sensitivity.  This outcome, coupled with 
the reduced metabolic rate in the morning, would delay the stimuli (i.e. hypoxia and 
hypercapnia) required to activate the effective recruitment threshold of upper airway 
motoneurons with the end result being an increase in breathing event duration. 
Physiological significance 
Increases in breathing event duration in the second half compared to the first half of the 
night in individuals with sleep apnea has been attributed to progressive diminution of feedback 
from upper airway sensory receptors in response to repeated trauma to pharyngeal tissues by 
upper airway vibration and closure (Cala et al., 1996).  In addition, it has been proposed that 
progressive exposure to intermittent hypoxia and accompanying increases in chemoreflex 
sensitivity could contribute to increased breathing instability in the latter half compared to the 
initial half of the night.  Thus, it has largely been accepted that consequences of sleep apnea (i.e. 
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intermittent hypoxia, inflammation) are responsible for altering the complexion of breathing 
events across the night (Deacon & Catcheside, 2014;Mahamed et al., 2003;Mateika, 2015).  In 
addition to these possibilities, our published findings (El-Chami et al., 2014a) and findings from 
the present investigation have shown that an endogenous rhythm may contribute to modification 
in breathing event characteristics.   This effect may be mediated through a time of day effect on 
chemoreflex properties (i.e. chemoreflex sensitivity and carbon dioxide reserve) in addition to an 
inherent modulation of upper airway patency.  Our findings lend credence to the possibility that 
consequences of sleep apnea are likely to interact with endogenous modulation of mechanisms 
that influence breathing instability.  Our results may have important implications for the 
development of novel therapies to treat sleep apnea. More specifically, the effect of time of day 
on the administered dose of therapies targeted toward mitigating diminution of upper airway 
muscle function or increases in chemoreflex sensitivity and decreases in the carbon dioxide 
reserve in the morning in patients with sleep apnea must be considered.  
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CHAPTER 3 - THE EFFECT OF TIME OF DAY ON CHEMOREFLEX SENSITIVITY 
AND THE CARBON DIOXIDE RESERVE DURING NREM SLEEP IN PARTICIPANTS 
WITH SLEEP APNEA 
(This chapter contains previously published material. See Appendix C) 
Introduction 
Clinical studies have reported that the number (Fanfulla et al., 1997; Salloum et al., 
2010) and duration of breathing events increase throughout the night (Charbonneau et al., 1994; 
Fanfulla et al., 1997; Salloum et al., 2010) and that this increase is independent of sleep 
architecture and body posture.  Likewise, a reduction in apneic events during daytime compared 
to nighttime sleep has been predicted by computer modeling simulations (Spengler et al. 2000), 
and supported by experimental evidence which showed that the apnea-hypopnea index was 
reduced during sleep in the day compared to the night in a small number of hypertensive men 
(Robin et al, 1958).   
The potential mechanisms underlying the increase in apnea severity are likely 
multifactorial and phenotypically dependent (Dempsey et al., 2010;Orr et al., 2014;Younes, 
2014).  One possibility is that increases in chemoreflex sensitivity, coupled to a reduction in the 
carbon dioxide reserve, are responsible for the progressive increase in breathing events across the 
night (Mateika & Narwani, 2009;Mateika & Syed, 2013a).  This suggestion is supported 
indirectly by Mahamed and colleagues, who reported that chemoreflex sensitivity to 
hypercapnia/hyperoxia increased during wakefulness in the morning, following six hours of 
sleep, compared to the evening in sleep apnea participants (Mahamed et al., 2005).  Sforza and 
colleagues also reported that respiratory drive, measured as the rate of increase in esophageal 
pressure during apneic events, gradually increased throughout the night even though the degree 
of oxygen desaturation and the rate of decrease in oxygen desaturation during apneic events were 
constant (Sforza et al., 1998).  These findings, along with the established understanding that 
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enhanced chemoreflex sensitivity promotes the occurrence of both central and obstructive 
breathing events provides support for the possibility that alterations in chemoreflex properties 
contribute to the promotion of breathing events at different points throughout the sleep period 
(Dempsey et al., 2004;Dempsey, 2005;Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika 
& Syed, 2013a;Yokhana et al., 2012).  
There are at least two possible mechanisms responsible for reported increases in 
chemoreflex sensitivity.  The first is that exposure to intermittent hypoxia during sleep is 
responsible for the reported increase in chemoreflex sensitivity during wakefulness in the 
morning compared to the evening in patients with sleep apnea (Mateika & Narwani, 
2009;Mateika & Syed, 2013a).  This hypothesis is supported by our work and others which have 
shown that exposure to intermittent hypoxia during wakefulness enhances chemoreflex 
sensitivity in healthy individuals (Griffin et al., 2012;Mateika et al., 2004a;Morelli et al., 
2004;Wadhwa et al., 2008) and individuals with sleep apnea (Gerst, III et al., 2011;Khodadadeh 
et al., 2006).  The second possibility is that alterations in chemoreflex properties reflect an 
endogenous oscillation that is linked to time of day. Indeed Spengler et al. (Spengler et al., 2000) 
and Stephenson et al. (Stephenson et al., 2000) have reported that chemoreflex sensitivity during 
wakefulness in healthy participants is modulated by a circadian rhythm.  Despite these findings, 
no studies have examined in individuals with sleep apnea if chemoreflex properties (i.e. apneic 
threshold, carbon dioxide reserve and chemoreflex sensitivity) are modulated during sleep 
according to the time of day and independent of intermittent hypoxia.  The present investigation 
was designed to fill this void. Based on the published literature we hypothesized that 
chemoreflex sensitivity would be greater and the carbon dioxide reserve reduced in the morning 
compared to measures obtained during sleep in the afternoon and evening.   
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Methods 
Protocol 
The Human Investigation Committees of Wayne State University School of Medicine 
and John D. Dingell Veterans Affairs Medical Center approved the experimental protocol.  Ten 
male participants with pure or predominantly obstructive (i.e., a central component combined 
with an obstructive component) sleep apnea but no other comorbidities (e.g., heart and lung 
disease, hypertension, and obesity) completed the protocol.  Participants that completed the 
protocol visited the laboratory on 6 occasions.  During the first visit to the laboratory, written 
informed consent was obtained and thereafter a physical examination, health and lifestyle 
questionnaires, blood pressure and lung volume measures along with a 12-lead EKG were 
completed.  After ensuring that inclusion criteria were met, participants completed a baseline 
nocturnal polysomnogram to confirm the presence of obstructive sleep apnea (visit 2). Upon 
verification, participants were enrolled into the protocol and given an actigraph watch 
(Actiwatch Spectrum, Philips Respironics Inc., Murraysville, PA).  The watch was used to 
monitor the sleep-wake schedule of the participants while they slept at home for two weeks prior 
to obtaining physiological measurements on visits 4-6 (see subsequent paragraph for further 
details).  We requested that the participants adhere to a regular sleep-wake schedule with a sleep 
onset time between 10-11 pm and a wake time of 7-8 am.  We also requested that the participants 
avoid daytime napping.  During the two week period the participants returned to the laboratory 
for a third visit.  During this visit continuous positive airway pressure was administered during 
sleep to determine the positive pressure required to maintain airway patency.  In addition, a 
“practice trial” using the methodology and procedures required to determine the apneic 
threshold, chemoreflex sensitivity and the carbon dioxide reserve was completed so that each 
participant experienced the required data collection methods and procedures prior to obtaining 
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formal measurements. 
After the two week time period participants returned to the laboratory on three separate 
occasions (i.e. visits 4-6).  Each of these visits was separated by a minimum of 7 days.  We 
requested that the participants maintain a regular sleep-wake schedule during the 7 day interval 
that separated each visit.  Details regarding two of the visits along with the corresponding results 
will be presented in separate publications.  During one of these visits core body temperature was 
measured for a minimum of 27 hours.  One of the final three visits was designed to measure the 
apneic threshold, chemoreflex sensitivity and carbon dioxide reserve at three time points during 
the day/night cycle.  Two days prior to these visits participants were asked to abstain from 
alcohol and caffeinated beverages.  On the day of the study participants arrived at the laboratory 
at approximately 7:30 pm.  Upon arrival the participants ingested a radiotelemetry pellet 
(CorTemp® Sensor, HQInc, Palmetto, FL) in order to measure core body temperature every 10 s 
throughout the visit.  This measure was used to establish the nadir of core body temperature and 
to confirm that this low point was similar to that measured during the study completed over a 
minimum time period of 27 hours.  Following instrumentation, participants slept for three hours 
during 3 separate sleep sessions (i.e. 10 pm - 1 am, 6 - 9 am, and 2 - 5 pm).  Subsequent to each 
sleep session participants were placed in a semi-recumbent position during wakefulness.  At the 
onset of each wake session (i.e. 1- 6 am and 9 am -2 pm) participants watched a movie for 120 
minutes and immediately thereafter read for 90 minutes.  Ninety minutes prior to the morning or 
afternoon sleep session the participants sat quietly and did not engage in any activity.  During 
each wake session participants received small snacks every 95 minutes composed of 
approximately 15 % fat, 75 % carbohydrate and 10 % protein.  Moreover, participants received 
up to a maximum of 1 liter of water over the length of the constant routine protocol.  During 
wakefulness the participants were in a dimly lit laboratory that was separated from sunlight and 
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external cues including phones, clocks, radios and television.  The laboratory temperature was 
controlled at 22-23°C. 
Interventions and procedures 
During each sleep session, nasal noninvasive positive pressure mechanical ventilation 
was used to induce hyperventilation to determine the hypocapnic ventilatory response and the 
apneic threshold (Figure 3A).  Mechanical ventilation was applied for 3 minutes in a 
spontaneous-timed pressure support mode, as described in previous publications (Mateika et al., 
2004b;Salloum et al., 2010).  In this mode, a backup respiratory rate of 6–8 breaths/min was 
preset and timed breaths delivered if the participant‘s respiratory rate fell below the set rate.  The 
ventilator respiratory rate, which was below the participant’s eupneic rate, was set to prevent 
neuromechanical inhibition of ventilatory motor output.  During mechanical ventilation, the 
inspiratory positive airway pressure was increased gradually in 1 to 2 cmH2O increments at the 
beginning of each mechanical ventilation trial, while the expiratory positive airway pressure was 
fixed throughout mechanical ventilation at a pressure that eliminated apnea but maintained a 
reduction in airflow of 15 - 20 % in each participant to prevent over distension of the airway.  
Mechanical ventilation was terminated after 3 minutes, during expiration, by returning the 
inspiratory positive airway pressure to the baseline expiratory positive airway pressure.  The 
ensuing hypocapnia resulted in either a hypopnea or central apnea (Figure 10A).  If an apnea was 
not induced, additional hyperventilation trials were completed until an apnea was evident or 
arousal from sleep prevented the completion of additional trials.  Central apnea was defined as an 
expiratory time ≥ 5 s.  Each hyperventilation trial was separated by a five minute period of 
baseline breathing. 
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Instrumentation 
During sleep studies the monitoring montage included an electroencephalogram (C3/A2, 
C4/A1, O1/A2, O2/A1), electrooculograms, submental electromyogram and an 
electrocardiogram.  Chest wall and abdominal movements were measured using inductive 
plethysmography (Respitrace, Ambulatory monitoring, Inc., Ardsley, NY).  Airflow and breath 
timing (inspiratory and expiratory time) were measured using a pneumotachometer (Model 
RSS100-HR, Hans Rudolph Inc., Shawnee, KS) attached to a nasal mask.  Oxygen saturation 
(SaO2) was measured with a pulse oximeter (Biox 3700; Ohmeda, Boulder, CO).  Measures of 
Figure 10. An illustration of the data collection and analysis procedures used to elicit a hypocapnic
induced apnea. (A) A single trial which shows that after measuring baseline ventilation and the
partial pressure of carbon dioxide (PETCO2), mechanical hyperventilation reduced carbon dioxide
levels below baseline.  Once mechanical ventilation ceased an apnea was evident during recovery.
(B) A scatterplot obtained from one participant illustrating the minute ventilation response to step-
wise reductions in PETCO2. In this example, reductions in PETCO2 occurred over 9 separate trials
(open circles) until an apnea was achieved. The difference between baseline PETCO2 and the PETCO2
that demarcated the apneic threshold was considered to be the carbon dioxide reserve.  The slope of
the regression line fit to the data points was considered to be the chemoreflex sensitivity. 
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end–tidal oxygen (Model 17515, Vacumed, Ventura, CA) and end–tidal carbon dioxide (Model 
17518, Vacumed Inc., Ventura, CA) were obtained from air expired into sampling tubes attached 
to ports on the face mask.  Nasal pressure was measured using a pressure transducer attached via 
tubing to a port on the nasal mask.  Upper airway pressure was measured using a transducer 
tipped catheter (Mikro-Cath 825-0101, Millar, Inc., Houston, TX) to confirm apnea and ascertain 
the presence of flow limitation.  All physiological variables were analogue to digitally converted 
at a sampling frequency of 100 Hz/channel and input into a computer using a commercially 
available software package (Gamma Version 4.0, Astro-Med Inc., West Warwick, RI).  The 
cardio-respiratory variables were also input into a second computer using a commercially 
available software package (WinDaq, Dataq Instruments Inc., Akron, OH).  
Data analysis 
All polysomnography studies were analyzed for sleep stage, arousals, and respiratory-
related events according to standard published criteria.  The hyperventilation trials completed 
during the evening, morning and afternoon sleep sessions were analyzed if associated with N2 or 
N3 of non-rapid eye movement sleep with an absence of arousal or ascent to N1.  For each trial 
within a given session, the baseline period was represented by breaths recorded during the two 
minutes that immediately preceded the onset of mechanical ventilation.  An average of the 
baseline periods measured during a given sleep session was calculated.  The average of the last 
five mechanically ventilated breaths before the ventilator was returned to a baseline expiratory 
positive airway pressure were averaged to represent the tidal volume achieved during the 
hyperventilation period.  The change in PETCO2 was calculated as the difference between the 
PETCO2 recorded during the control period and the PETCO2 associated with the last five 
mechanically ventilated breaths.  Minute ventilation was given a value of 0 once a central apnea 
was induced. 
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The apneic threshold was defined by the PETCO2 associated with the occurrence of an 
apnea (Figure 10B).  The carbon dioxide reserve was defined as the difference in PETCO2 
measured during baseline breathing and the PETCO2 that demarcated the occurrence of an apnea 
(Figure 10B).  Chemoreflex sensitivity was determined by dividing the change in minute 
ventilation (i.e. the difference between minute ventilation measured during baseline and minute 
ventilation measured once the ventilator was returned to an expiratory positive airway pressure) 
and the change in PETCO2 (i.e. the difference between PETCO2 measured during baseline and the 
PETCO2 that demarcated an apnea) (Figure 10B).  
Measurements of core body temperature were purified to eliminate small fluctuations in 
temperature associated with movements during wakefulness that occurred during feeding or 
bathroom breaks.  Thereafter, the temperature was fit with a cosine wave (y = m + acos 
(2πt/ω+ϕ); where y is the temperature, m is the circadian rhythm adjusted mean (i.e. mesor), a is 
the amplitude of the circadian rhythm, t is time (hours), ω is the period of the circadian rhythm, ϕ 
is the phase angle.  Once the phase and period of the core body temperature was established for 
an individual, this information was used to assign a circadian phase (from 0 to 359°) to each 
minute, with 0° corresponding to the minimum of the waveform fitted to the core body 
temperature data.  The plotted data was then used to determine the session that corresponded to 
the core body temperature nadir.   
Statistical analysis 
A one-way repeated measures analysis of variance in conjunction with Student-Newman 
Keuls post hoc test was used to compare baseline levels of PETCO2 and minute ventilation, the 
PETCO2 that demarcated the apneic threshold, chemoreflex sensitivity and the carbon dioxide 
reserve measured during the evening, morning and afternoon sleep sessions.  Data are presented 
as means along with individual data points to signify variability.  A p value ≤ 0.05 was 
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considered statistically significant.   
Results 
Table 3 shows the anthropometric variables obtained for the group.  The results show that 
the participants were young, and not obese as indicated by the body mass index.  The 
apnea/hypopnea index ranged from mild to severe according to standard criteria.  However, the 
level of oxygen desaturation achieved during apneic/hypopneic events was mild even in those 
participants considered to have severe sleep apnea.  Systolic and diastolic blood pressure 
measurements were within normal limits and the Epworth sleepiness scale indicated a history of 
mild sleepiness while scores from the Stanford sleepiness scale indicated normal alertness for 
both groups on the day of the screening visit (Table 3).  The average therapeutic pressure 
required to eliminate apnea during sleep on visit 2 in the OSA participants was 11.2 ± 0.7 
cmH2O.  
Table 3. Baseline anthropometric, blood pressure and sleep measures 
Variable  
Age, yr. 29.8 ± 2.1 
Height, cm 172.5 ± 5.0 
Weight, kg 80.7 ± 3.2 
Body mass index, kg/m2 26.2 ± 0.7 
Systolic pressure, mmHg 121.7 ± 2.0 
Diastolic pressure, mmHg 74.2 ± 2.9 
Epworth Sleepiness Scale 10.3 ± 1.3 
Apnea/hypopnea index, events/hr 39.1 ± 5.1 
Lowest oxygen desaturation during apnea, % 87.5 ± 1.1 
Race 6 AA, 2 Caucasian, 1 Asian, 1 Indian 
The nadir of core body temperature was evident during the morning session (Figure 11). 
Baseline measures of minute ventilation were lower in the morning compared to values in the 
evening (p < 0.02) and afternoon (p < 0.02) (Figure 12A).  A corresponding decrease in tidal 
volume (Figure 12B), but not breathing frequency (Figure 12C), was evident in the morning 
compared to the evening (p < 0.04) and afternoon (p < 0.04).  Baseline PETCO2 was reduced in 
the morning (p < 0.002) and afternoon (p < 0.02) compared to the evening (Figure 13); while the 
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PETCO2 values that demarcated the apneic threshold were similar across the evening, morning 
and afternoon sessions (Figure 13).  The carbon dioxide reserve was reduced in the morning (2.1 
± 0.25 mmHg) compared to the evening (3.6 ± 0.5 mmHg) (p < 0.002) and afternoon (3.5 ± 0.3 
mmHg) (p < 0.001) (Figure 13), while chemoreflex sensitivity was increased in the morning 
compared to the evening (p < 0.001) and afternoon (p < 0.001) (Figure 12D).   
 
 
  
Figure 11. Average values of core body temperature of 10 participants with sleep apnea shown
in 30 minute increments over a 24 hour cycle. Note that the nadir in temperature occurred at 6
am and the peak at 7:30 pm (vertical arrows). Zero time represents the onset of the temperature
recording (9:00 p.m.).
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Figure 12. Combined histograms and scatterplots which show the group mean, and mean values
for each participant, calculated from measures of (A) baseline minute ventilation (B) baseline
tidal volume (C) baseline breathing frequency and (D) the hypocapnic ventilatory response,
during the evening, morning and afternoon sleep sessions. Note that minute ventilation along
with tidal volume was reduced and the hypocapnic ventilatory response increased in the
morning compared to the afternoon and evening. † significantly different compared to the
evening and afternoon. 
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Discussion 
We employed a constant routine protocol to measure chemoreflex properties during non-
rapid eye movement sleep across the 24-hour cycle in participants with sleep apnea.  Our 
primary findings were that the carbon dioxide reserve was reduced and chemoreflex sensitivity 
was increased during sleep in the morning compared to the evening and afternoon.    
Baseline measures of ventilation PETCO2, temperature and time of day 
Previous studies have employed constant routine protocols to directly measure ventilation 
over a 24 hour period of wakefulness in healthy humans breathing room air (Adamczyk et al., 
2008;Spengler et al., 2000;Vargas et al., 2001), or breathing air comprised of elevated levels of 
carbon dioxide (Stephenson et al., 2000) or reduced levels of oxygen (Vargas et al., 2001).  
Figure 13. Combined histograms and scatterplots which show the group mean, and mean values
for each participant, calculated from baseline measures of the partial pressure of carbon dioxide
(PETCO2) (group average indicated by top of the gray bars and individual data indicated by the
black circles), the PETCO2 that demarcates the apneic threshold (group average indicated by
bottom of the gray bars and individual data indicated by white circles) and the carbon dioxide
reserve indicated by the vertical dashed line parallel to each histogram bar.  Note that baseline
PETCO2 was reduced in the morning and afternoon compared to the evening (*) and that the
carbon dioxide reserve was reduced in the morning compared to the evening and afternoon (†). 
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Collectively, a circadian oscillation in minute ventilation (Adamczyk et al., 2008;Spengler et al., 
2000;Stephenson et al., 2000), or it components tidal volume and breathing frequency 
(Adamczyk et al., 2008), has been reported; although the circadian rhythm of minute ventilation 
approached but did not reach statistical significance in one investigation (Spengler et al., 2000).  
The nadir of minute ventilation occurred in the early morning in the majority of studies 
(Adamczyk et al., 2008;Stephenson et al., 2000), but in one case was evident in the early 
evening (Spengler et al., 2000).  Our results are similar to published findings since a significant 
reduction in minute ventilation and tidal volume was evident in the morning compared to the 
evening and afternoon.  
Mortola suggested that circadian variations in minute ventilation in humans are mediated 
almost exclusively by changes in arousal state under the normal light dark routine accompanied 
by fluctuations in sleep and wakefulness (Mortola, 2004).  However, our results, coupled with 
previous findings (Adamczyk et al., 2008;Spengler et al., 2000;Stephenson et al., 2000), indicate 
that the observed fluctuations in minute ventilation are in part influenced by the time of day, 
since fluctuations are evident under constant routine conditions when wakefulness and sleep are 
controlled.  Although the fluctuation in minute ventilation is small, it is robust, since it remained 
evident despite variability in the constant routine protocols employed in published studies 
(Adamczyk et al., 2008;Spengler et al., 2000;Stephenson et al., 2000) and the present 
investigation (e.g. 24 hours of sleep deprivation vs. 3 hour sleep sessions interspersed with 
wakefulness).  Thus, our results, coupled with previous findings, have established that minute 
ventilation varies according to the time of day during both non-rapid eye movement sleep and 
wakefulness in humans.   
In addition to examining the effect of time of day on minute ventilation, simultaneous 
measures of core body temperature and PETCO2 over a 24 hour period of wakefulness, while 
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breathing room air, has also been measured in a few studies (Spengler et al., 2000;Stephenson et 
al., 2000;Vargas et al., 2001).  In these studies a well-established oscillation in core body 
temperature (Hofstra & de Weerd, 2008) was evident with the nadir occurring during the early 
morning hours (i.e. 6 - 8 am) (Spengler et al., 2000;Stephenson et al., 2000;Vargas et al., 2001).  
However, the relationship between minute ventilation and core body temperature varied, with 
core body temperature in phase with minute ventilation in one investigation (Stephenson et al., 
2000) but lagging 6-8 hours in another (Spengler et al., 2000).    
An obvious but small oscillation (~ 1-2 mmHg) in PETCO2 has also been documented 
(MILLS, 1953;Spengler & Shea, 2000;Vargas et al., 2001), and the relationship between minute 
ventilation and PETCO2 was reportedly in phase (i.e. decreases in ventilation were accompanied 
by decreases in PETCO2) with the nadir of the measures occurring between 6 pm and midnight 
(Spengler & Shea, 2000).  In agreement with previous findings we showed in the present 
investigation that the nadir of core body temperature occurred in the early morning hours.  
Moreover, minute ventilation and PETCO2 were significantly lower during sleep in the morning 
compared to the evening and afternoon.  Given that we were not able to obtain continuous 
measures during sleep over the period of our investigation we cannot state definitely that minute 
ventilation and PETCO2 were in phase with the nadir of core body temperature.  However, given 
our results it is unlikely that the nadir of core body temperature lagged minute ventilation and 
PETCO2 to the degree reported in a previous investigation (Spengler & Shea, 2000).   
It has long been established that PETCO2 is influenced by arousal state, increasing during 
sleep compared to wakefulness (Mortola & Maskrey, 2011;ROBIN et al., 1958).  However, our 
results, along with previous findings (MILLS, 1953;Spengler et al., 2000;Vargas et al., 2001), 
confirm that within a sleep or wake state PETCO2 is effected by the time of day.  Moreover, our 
results reveal that a coincident reduction in minute ventilation and PETCO2 occurred in 
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conjunction with core body temperature.  The mechanism responsible for the coincidental nadir 
in minute ventilation and PETCO2 during the morning or the increase in minute ventilation and 
PETCO2 in the other sessions is unknown.  However, given the increase in chemoreflex 
sensitivity (see Chemoreflex properties and time of day for further discussion) that we measured 
in the morning, compared to the afternoon and evening, it seems unlikely that chemoreflex inputs 
were principally responsible for the coincidental decrease in ventilation and PETCO2 observed in 
our investigation.  This finding is intriguing, since it is generally accepted that minute ventilation 
during non-rapid eye movement sleep is controlled solely by input from the chemoreflexes in 
healthy humans (Phillipson EA & Bowes G, 1986).  Alternatively, given the coincident 
variations in core body temperature, minute ventilation and PETCO2 in the present investigation, 
coupled with similar published findings that included measures of metabolic rate during 
wakefulness (Spengler et al., 2000), indicates a robust link between minute ventilation and 
metabolism.  Despite this result the mechanism responsible for the link between metabolism and 
minute ventilation remains unknown.  Perhaps parallel inputs to the respiratory controller and 
temperature regulation network is responsible for the coincident reduction in minute ventilation, 
PETCO2 and temperature that was observed.  Indeed, activation of the nucleus tractus solitarius 
and ventrolateral medulla in rats induces a coincident decrease in temperature and PETCO2 (Cao 
et al., 2010). 
Chemoreflex properties and time of day 
A number of studies have examined the effect of time of day on chemoreflex properties 
in healthy humans during wakefulness (Fuse et al., 1999;Mahamed et al., 2005;Raschke & 
Moller, 1989;Siekierka et al., 2007;Spengler et al., 2000;Stephenson et al., 2000).  Some studies 
were designed to measure the threshold and/or chemoreflex sensitivity in the evening, prior to 
sleep, and in the morning, immediately after sleep (Fuse et al., 1999;Mahamed et al., 2005).  The 
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results were variable in that the ventilatory response to increases in carbon dioxide during 
wakefulness were reported to be unchanged (Fuse et al., 1999) or altered as a consequence of a 
decrease in the chemoreflex threshold (Mahamed et al., 2005) in the morning compared to the 
evening.  Differences in the methodology used to measure chemoreflex properties, and the 
composition of populations recruited for each study could account for some of the variability 
(Fuse et al., 1999;Mahamed et al., 2005).  Nonetheless, despite this variability the reported 
change (Mahamed et al., 2005) or lack thereof (Fuse et al., 1999) would tend to promote the 
maintenance of breathing stability across the  evening to morning transition. 
Other studies have measured chemoreflex properties in healthy humans over a 24 hour 
period (Raschke & Moller, 1989;Siekierka et al., 2007;Spengler et al., 2000;Stephenson et al., 
2000).  In two studies the participants were awake and inactive throughout the constant routine 
protocol (Spengler et al., 2000;Stephenson et al., 2000).  In the remaining studies measurements 
were also made during wakefulness (Raschke & Moller, 1989;Siekierka et al., 2007); however 
participants were either allowed to sleep at will (Raschke & Moller, 1989), or sleep for 2 hours 
from 4-6 a.m. in addition to engaging in moderate physical activity (Siekierka et al., 2007).  
Results from these studies revealed that a circadian oscillation in the ventilatory response to 
isocapnic hypoxia (Raschke & Moller, 1989;Siekierka et al., 2007) or the ventilatory response to 
carbon dioxide in the presence of normoxia (Raschke & Moller, 1989;Spengler et al., 2000) or 
hypoxia (Stephenson et al., 2000) was evident.  The acrophase of the ventilatory response to 
isocapnic hypoxia reportedly occurred at noon and remained relatively constant at other times 
throughout the 24 hour cycle (Siekierka et al., 2007).  Inclusion of exercise and one period of 
sleep in the constant routine protocol may have influenced the results (Siekierka et al., 2007).  
Spengler and Shea reported that the acrophase of the ventilatory response to carbon dioxide (i.e. 
as a result of an increase in chemoreflex sensitivity) was evident between the hours of 10 a.m. 
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and 2 p.m., while the bathyphase which was evident starting at 6 pm remained stable for 12-14 
hours (Spengler et al., 2000).  In other studies the acrophase of the ventilatory response to carbon 
dioxide, either as a consequence of an increase in the chemoreflex threshold (Stephenson et al., 
2000) or a decrease in chemoreflex sensitivity (Raschke & Moller, 1989), was evident later in 
the evening (6 p.m.) while the onset of the bathyphase was manifested in the morning (Raschke 
& Moller, 1989;Stephenson et al., 2000).  Although some discrepancies exist between studies, 
collectively the results suggest that the ventilatory response to hypoxia or carbon dioxide may 
remain relatively stable or decrease across the hours normally associated with sleep in healthy 
humans.  
To our knowledge only two studies have explored the effect of time of day on 
chemoreflex properties in participants with sleep apnea (Fuse et al., 1999;Mahamed et al., 2005).  
In both studies measures of the chemoreflex threshold (Mahamed et al., 2005) and/or 
chemoreflex sensitivity (Fuse et al., 1999;Mahamed et al., 2005) were obtained during 
wakefulness in the evening, prior to sleep, and in the morning, immediately after sleep (Fuse et 
al., 1999;Mahamed et al., 2005).  Mahamed and colleagues reported that the chemoreflex 
sensitivity to hyperoxia/hypercapnia was increased in the morning compared to the evening 
(Mahamed et al., 2005), while Fuse reported that no changes in chemoreflex sensitivity were 
evident (Fuse et al., 1999).  Mahamed and colleagues (Mahamed et al., 2005) suggested that the 
reasons for the discrepant findings was that Fuse et al. (Fuse et al., 1999) used a standard 
hyperoxic rebreathing technique that measures ventilatory responses in the hypercapnic range of 
50–80 mmHg, whereas Mahamed at al. used a  modified rebreathing technique that measures 
ventilation in the normocapnic range of 35–60 mmHg (Mahamed et al., 2005).  Independent of 
this difference, the design of both studies eliminated the possibility of examining the effect of 
time of day on chemoreflex properties in humans with obstructive sleep apnea during sleep.  
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More specifically, measures were not obtained during sleep so that measures of chemoreflex 
properties during wakefulness in the morning were likely impacted by stimuli linked to breathing 
events (e.g. arousal, intermittent hypoxia) that occurred during the preceding sleep period (Fuse 
et al., 1999;Mahamed et al., 2005).  Our primary findings filled this void and revealed that the 
ventilatory response to hypocapnia was significantly enhanced, while the carbon dioxide reserve 
was reduced, in the morning compared to the evening and afternoon.  Conversely, the PETCO2 
that demarcated the apneic threshold remained stable across the 3 sleep sessions.  Given this 
stability, the reduction in the carbon dioxide reserve in the morning was due principally to a 
reduction in baseline carbon dioxide.  Thus, a fundamental alteration in chemoreflex properties 
linked solely to the time of day might exist in sleep apnea participants compared to healthy 
humans, if our analysis of the published results from healthy humans is correct (see preceding 
paragraph for further discussion). 
Physiological significance 
A few clinical studies have reported that the number (Fanfulla et al., 1997;Sforza et al., 
1998) and duration (Cala et al., 1996;Charbonneau et al., 1994;Sforza et al., 1998) of breathing 
events increase throughout the night independent of sleep architecture and body posture.  
Likewise, a reduction in apneic events during daytime compared to nighttime sleep has been 
predicted by computer modeling simulations (Stephenson, 2004), and supported by experimental 
evidence which showed that the apnea-hypopnea index was reduced during sleep in the day 
compared to the night in a small number of hypertensive men (Scharf et al., 1990).    
The duration of breathing events might be increased as a consequence of diminished 
feedback from upper airway sensory receptors which Cala and colleagues have suggested is due 
to repeated trauma to pharyngeal tissues as a consequence of upper airway vibration and closure 
(Cala et al., 1996).  Alternatively, an increase in breathing instability and the number of events 
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from the beginning to the end of the night may be driven by an increase in chemoreflex 
sensitivity and a reduction in the carbon dioxide reserve, respectively (Mateika & Narwani, 
2009;Mateika & Syed, 2013a).  Indeed our findings support this suggestion, since chemoreflex 
sensitivity was increased and the carbon dioxide reserved decreased in the morning compared to 
the afternoon and evening.  
One of the stimuli which could initiate increases in chemoreflex sensitivity is intermittent 
hypoxia, a hallmark of sleep apnea (Mateika & Narwani, 2009;Mateika & Syed, 2013a).  Indeed 
numerous studies reported that exposure to intermittent hypoxia during wakefulness increases 
the ventilatory response to carbon dioxide and sustained hypoxia (Gerst, III et al., 
2011;Khodadadeh et al., 2006;Mateika et al., 2004a;Morelli et al., 2004;Wadhwa et al., 2008).  
However, questions remained regarding whether or not chemoreflex properties were altered over 
time during sleep in participants with sleep apnea.  Our results have partially filled this void, 
since we established that chemoreflex sensitivity is increased and the carbon dioxide reserved is 
decreased in the morning compared to the afternoon and evening.  We also ascertained that these 
alterations were linked to the time of day independent of exposure to intermittent hypoxia.  Thus, 
progressive increases in chemoreflex sensitivity during sleep in participants with sleep apnea 
could in part be the cause and not the consequence of breathing events.  Our findings may have 
important implications for the development of novel therapies to treat sleep apnea.  More 
specifically, the effect of time of day on the administered dose of pharmaceuticals agents 
targeted toward mitigating the impact that increases in chemoreflex sensitivity and/or decreases 
in the carbon dioxide reserve have on breathing instability in patients with sleep apnea should be 
considered (Wang et al., 2013).  
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CHAPTER 4 - IMPACT OF AROUSAL THRESHOLD AND CHEMOREFLEX 
SENSITIVITY ON APNEA FREQUENCY AND DURATION IN PARTICIPANTS WITH 
SLEEP APNEA 
Introduction 
We reported that the frequency and duration of apneic events is dependent on sleep stage 
(El-Chami et al., 2015).  More specifically, we showed that the duration and frequency of events 
was greater in N2 compared to N1 sleep, independent of the time of day (El-Chami et al., 2015).  
The observed increase in event duration in N2 could be caused by an increase in the arousal 
threshold, along with an increase in the effective recruitment threshold for upper airway muscle 
activity (Cala et al., 1996;Eckert & Younes, 2014b;Montserrat et al., 1996b).  Alternatively, a 
blunted respiratory response to afferent inputs (e.g. chemoreflex and mechanoreceptor inputs), 
reflected by a decrease in the rate of change of respiratory effort during apneic events in N2 
could be responsible for sleep stage related differences in apneic duration.  The relationship 
between event duration and arousal threshold or respiratory response sensitivity should impact 
on respiratory effort immediately prior to termination of an event, and closely after establishment 
of airway patency.   
Kimoff and colleagues reported that the rate of change of respiratory effort during 
breathing events in N2 is independent of event duration (Cala et al., 1996;Montserrat et al., 
1996b).  Thus, respiratory effort at the termination of an event might reflect increases in the 
arousal or effective recruitment threshold.  If these findings are consistent across sleep states the 
rate of change of respiratory effort during events in N1 compared to N2 may be similar.  
However, the maximum response at the termination of an event and immediately upon re-
establishment of upper airway patency may be increased if the arousal threshold or effective 
recruitment threshold is increased in N2 compared to N1.  The present investigation was 
completed in part to test this hypothesis.    
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In addition to the variation in event duration and frequency in N2 compared to N1, we 
also recently reported that event duration was greater in the morning compared to the afternoon 
and evening within a given sleep stage (i.e. N2) (El-Chami et al., 2015), consistent with previous 
published findings (Cala et al., 1996;Charbonneau et al., 1994;Fanfulla et al., 1997;Lavie et al., 
1981;Montserrat et al., 1996a;Sforza et al., 1998).  Likewise, event frequency was greater in the 
morning during N1 (El-Chami et al., 2015).  We provided evidence which suggested that the 
effect of time of day on the duration and frequency of breathing within a given stage of sleep 
might be mediated by a circadian variation in both chemoreflex sensitivity (El-Chami et al., 
2014b), and upper airway collapsibility (El-Chami et al., 2015).  Explicitly, we found that an 
increase in chemoreflex sensitivity coupled to a decrease in the carbon dioxide reserve, and a 
more collapsible airway, was evident in the morning during N2 compared to the afternoon and 
evening (El-Chami et al., 2014b).  These findings were evident despite the absence of hallmarks 
of sleep apnea (i.e. intermittent hypoxia) (El-Chami et al., 2014b).  
The variation in chemoreflex properties could result in an increased rate of change in 
respiratory effort during an event in a given stage based on the time of day.  This postulation is 
supported by the findings of Sforza et al. (Sforza et al., 1998) but is in contrast to the findings of 
Kimoff and colleagues who reported that the rate of change of respiratory effort modified by 
pressure changes that activate upper airway mechanoreceptors, or increases in central respiratory 
drive, was not altered by the time of day (Cala et al., 1996;Montserrat et al., 1996b).  Likewise, 
variations in chemoreflex properties, coupled to a more collapsible airway and consequently an 
increased effective recruitment threshold, could result in an upsurge in respiratory effort 
immediately at the termination of an event and following re-establishment of airway patency (El-
Chami et al., 2015).  The increase in effort following re-establishment of airway patency could 
lead to hypocapnia and the initiation of subsequent events upon re-establishing the sleep state 
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(Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika & Syed, 2013b).  This postulation is 
supported indirectly by Kimoff and colleagues (Cala et al., 1996;Montserrat et al., 1996b) who 
showed that the respiratory effort immediately prior to termination of the event was greater in the 
morning compared to the evening.  To test the hypotheses stated above respiratory effort during 
events, immediately prior to termination of events, and closely after establishing airway patency 
was measured during N1 and N2 of non-rapid eye movement sleep in the evening and morning 
in individuals with obstructive sleep apnea.  
Methods 
Protocol 
Findings discussed in this chapter resulted from the same visits we conducted to measure 
the frequency and duration of breathing events at different times of the day.  For a detailed 
description of the protocol and instrumentation, refer to the protocol section of Chapter 2.  
Data analysis 
All polysomnography studies were analyzed for sleep stage, arousals, and respiratory-
related events in accordance with standard published criteria.  An apnea was identified as an 
event in which there was a cessation of inspiratory airflow for a minimum of 10 s.  An event 
accompanied by a > 50% reduction in airflow that lasted for a minimum of 10 s and was 
accompanied by either an arousal, or a ≥ 3% reduction in oxygen saturation in the absence of an 
arousal, was classified as a hypopnea.  The duration and number of apneas and hypopneas, along 
with the decrease in oxygen saturation that occurred during each event, was established for N1 
and N2 of non-rapid eye movement sleep for each sleep session completed during Visit 4.  The 
rate of change of upper airway inspiratory pressure from the start to the end of each breathing 
event (∆ pressure ÷ ∆ time) detected during N1 and N2 sleep was determined (Figure 14).  
Analyses of events recorded in N3 were excluded from the results because the total amount of 
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time spent in N3 was insufficient to make comparisons between participants or sleep sessions.  
The lowest airway inspiratory pressure associated with the last respiratory attempt prior to 
termination of each event was also ascertained (Figure 14).  Lastly, the tidal volume response of 
Figure 14. A raw figure showing the various parameters analyzed during an apneic event
appearing in non-rapid eye movement sleep.  Note that upper airway pressure was measured at
the beginning and immediately prior to the termination of an event (see upper airway pressure
– B and E).  In addition, the difference between these measures (see upper airway pressure –
delta) divided by the duration of the event was used to determine the rate of change of the
respiratory effort during an event.  Lastly, note that immediately following the termination of
an event the maximum tidal volume and the lowest partial pressure of end-tidal carbon dioxide
(PETCO2) within the initial 3 breaths after event termination was recorded. 
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the greatest magnitude, coupled with the accompanying fractional concentration of end-tidal 
carbon dioxide, was recorded from 1 of the initial 3 breaths after termination of a breathing event 
(Figure 14).  
The decrease in carbon dioxide associated with the breath of the greatest magnitude 
following a breathing event was subtracted from baseline measurements of the partial pressure of 
end-tidal carbon dioxide measured from a 2-min period of stable non-rapid-eye-movement sleep 
during the evening and morning sleep sessions completed during visit 5 or 6 (El-Chami et al., 
2015;El-Chami et al., 2014b).  Baseline measures were obtained from these visits because a 
patent airway was established with continuous positive airway pressure in contrast to visit 4 in 
which a stable baseline period was not available to obtain baseline measures of the fractional 
concentration of carbon dioxide.   
Statistical analysis  
A two-way repeated measures ANOVA in conjunction with Fisher’s least square 
difference post hoc test was used to compare the rate of change of respiratory effort, maximum 
effort immediately prior to event termination as well as the tidal volume and partial pressure of 
end-tidal carbon dioxide immediately after establishing airway patency.  The two factors in the 
analysis were sleep stage (i.e. N1 and N2) and time of day (i.e. evening and morning).  A paired 
t-test was used to compare the difference in the partial pressure of end-tidal carbon dioxide 
induced by hyperventilation and carbon dioxide measures that demarcated the apneic threshold 
obtained during N2 in the evening and morning.  The end-tidal carbon dioxide measures were 
standardized to baseline measures. 
Results 
Table 4 shows the anthropometric variables obtained for the group.  The participants 
were young to middle age, and not obese, as indicated by the body mass index.  The 
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apnea/hypopnea index determined from the screening sleep study (i.e. Visit 2) ranged from mild 
to severe according to standard criteria.  The level of oxygen desaturation achieved during 
apneic/hypopneic events was mild even in those participants considered to have severe sleep 
apnea.  Systolic and diastolic blood pressure measurements were within normal limits and the 
Epworth sleepiness scale indicated a history of mild sleepiness (Table 4).  The nadir of core body 
temperature was evident in the early morning during visit 4.  Participants spent 73.4 ± 4.9 % and 
78.0 ± 2.7 % of the total session time (i.e. 3 hours) in non-rapid eye movement sleep in the 
evening and morning (P ≥ 0.47) during visit 4.  The percentage of time spent in N1 or N2 for a 
given 3-hour sleep session was not significantly different between the evening and morning (P ≥ 
0.85).   
Table 4: Baseline anthropometric, blood pressure and sleep measures  
Variable  
Age, yr. 29.6 ± 2.3 
Height, cm 177.1 ± 2.1 
Weight, kg 83.8 ± 2.6 
Body mass index, kg/m2 26.6 ± 0.7 
Systolic pressure, mmHg 118.7 ± 3.1 
Diastolic pressure, mmHg 70.9 ± 3.0 
Epworth Sleepiness Scale 10.0 ± 1.2 
Apnea/hypopnea index, events/hr 44.4 ± 5.2 
Lowest oxygen desaturation during apnea, % 86.5 ± 1.3 
Race 6 AA, 3 Caucasian, 1 Asian, 1 Indian 
Values are means ± SE 
Respiratory effort was measured from an average of 48.8 ± 10.2 events during N1 and 
from 178.1 ± 25.2 events during N2 in each participant.  The rate of change of respiratory effort 
during N1 compared to N2 was not significantly different (P = 0.83) (Figure 15A).  Conversely, 
the upper airway inspiratory pressure associated with the last respiratory attempt prior to event 
termination was greater during N2 compared to N1 (P  0.04) (Figure 15B).  This increase was 
accompanied by a greater decrease in oxygen saturation in N2 compared to N1 (P  0.002) 
(Figure 15C).  Likewise, following event termination tidal volume was greater (P  0.03) (Figure 
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15D) and the partial pressure of end-tidal carbon dioxide was less (P  0.05) (Figure 15E) in N2  
 
 
 
compared to N1.  Respiratory effort during events and the magnitude of tidal volume after event 
termination was unrelated to the degree of flow limitation during hypopneic events which was 
similar in N1 compared to N2 (48.1 ± 2.2 vs. 47.4 ± 2.4 % of baseline, P = 0.34).  Likewise, the 
number of events associated with an arousal at event termination (expressed as a percentage of 
the total number of events) was similar in N1 compared to N2 (77.3 ± 4.4 vs. 82.9 ± 4.0 % of 
events, P = 0.18).  Thus, the presence or absence of an arousal at the termination of an event 
Figure 15. Histograms (mean ± S.E.) showing the rate of change in epiglottic pressure (A),
epiglottic pressure at the termination of an event (B), change in oxygen saturation during events
(C), maximum tidal volume immediately following an event (D), lowest partial pressure of end-
tidal carbon dioxide (PETCO2) immediately following an event (E) and duration of breathing
events (F) during N1 (white histograms) and N2 (gray histograms) of non-rapid eye movement
sleep.  ‡ significantly different from N1; * significantly different from the evening. 
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likely did not account for differences in post event measures of tidal volume.  The increase in 
respiratory effort during and following events in N2 were coupled to an increase in event 
duration during N2 compared to N1 (P  0.004) (Figure 15F). 
The rate of change of respiratory effort was similar in the evening compared to the 
morning (P = 0.34) (Figure 15A), as was the upper airway inspiratory pressure measured for the 
last respiratory event prior to event termination (P = 0.88) (Figure 15B) and the decrease in 
oxygen saturation (P = 0.13) (Figure 15C).  In contrast, following event termination, tidal 
volume was greater (P  0.01) (Figure 15D) and consequently the partial pressure of end-tidal 
carbon dioxide was less (P  0.05) (Figure 15E) in the morning compared to the evening 
independent of sleep stage.  The decrease in the partial pressure of carbon dioxide in response to 
hyperventilation in the morning was below the apneic threshold compared to the partial pressure 
of end-tidal carbon dioxide which remained slightly above the apneic threshold in the evening (P 
 0.02) (Figure 16).  The duration of events was greater in the morning compared to the evening 
independent of sleep stage (P  0.001) (Figure 15F).    
 
Figure 16. Histograms which show
the group mean values calculated
from baseline measures of the partial
pressure of end-tidal carbon dioxide
(PETCO2), the PETCO2 that demarcates
the apneic threshold (AT) which was
previously published and the lowest
PETCO2 measured immediately
following breathing events in the
present investigation (dashed line;
PH–post hyperventilation). Note that
in the morning the PETCO2 initiated
by post hyperventilation was below
the apneic threshold in contrast to the
evening. † PETCO2 initiated by PH
standardized to the AT significantly
different in the morning compared to
the evening. 
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Discussion 
We discovered that the rate of change of respiratory effort during breathing events was 
similar throughout N2 and N1, even though the duration of events was greater in N2 compared to 
N1.  Coupled to the increase in duration the respiratory effort immediately prior to and after 
termination of an event was greater in N2 compared to N1.  The increase in respiratory effort 
(i.e. tidal volume) after termination of an event was coupled to a reduced partial pressure of end-
tidal carbon dioxide.  We also found that within a given stage of non-rapid eye movement sleep 
(i.e. N1 or N2) the rate of change of respiratory effort and the maximum respiratory effort 
immediately prior to termination of an event was similar in the morning compared to the 
evening, whereas the duration of breathing events was greater in the morning.  Despite the 
similarity in respiratory effort during events, tidal volume was greater and the partial pressure of 
end-tidal carbon dioxide was reduced once airway patency was re-established in the morning 
compared to the evening. 
Mechanisms responsible for the increase in event frequency & duration in N2 compared to N1 
In our previous investigation we found that the duration of breathing events was 
increased during N2 compared to N1 of non-rapid eye movement sleep.  At least two 
mechanisms could be responsible for the increase as outlined above (see Introduction).  The 
increase could be caused by a rise in the arousal threshold along with an increase in the effective 
recruitment threshold for upper airway muscle activity.  Alternatively, a blunted respiratory 
response to afferent inputs (e.g. chemoreflex and mechanoreceptor inputs) reflected by a 
decrease in the rate of change of respiratory effort during apneic events in N2 could be 
responsible for sleep stage related difference in apnea duration.  Kimoff and colleagues reported 
that the rate of change of respiratory effort during breathing events in N2 is independent of event 
duration (Cala et al., 1996;Montserrat et al., 1996b).  If this finding is consistent across sleep 
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states then a similar rate of change of respiratory effort during events in N2 compared to N1 
would be expected.  This expectation was confirmed by our results which showed that the rate of 
change of respiratory effort was similar in N2 compared to N1.  In contrast, we showed that the 
respiratory effort immediately prior to termination of events in N2 was greater compared to N1.  
Thus, our results imply that increases in the arousal threshold and effective recruitment threshold 
had a role in the prolongation of event duration during N2 compared to N1.   
Our results also showed that the magnitude of the tidal volume response was greater and 
the partial pressure of end-tidal carbon dioxide was reduced immediately following termination 
of breathing events in N2 compared to N1.  The increase in the tidal volume response was 
independent of the degree of flow limitation and the number of events accompanied by arousal.  
Thus, we propose that an elevated arousal threshold leading to an increase in event duration 
during N2 was accompanied by enhancement of respiratory stimuli that contributed to the 
augmented tidal volume response evident following termination of events in N2.  This 
suggestion is supported by our results which showed a greater decrease in oxygen saturation 
during events in N2.  Consequently, termination of an event was likely accompanied by 
increased chemoreceptor input (Pillar et al., 2000;Loewen et al., 2011b;Nicholas et al., 
2010;Saboisky et al., 2010b;Stanchina et al., 2002), along with other sensory inputs (Berry et al., 
1995;Cala et al., 1996;McNicholas et al., 1987), that initiated increases in tidal volume coupled 
with reductions in the partial pressure of end-tidal carbon dioxide that exceeded measures 
following events in N1.  Independent of the mechanisms responsible for the increased end-apnea 
ventilatory response the accompanying hypocapnia could increase the likelihood of perpetuating 
apneic events in N2 compared to N1 (Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika 
& Syed, 2013b).  This suggestion is supported by our previous findings which showed that the 
frequency of breathing events was increased in the evening and afternoon in N2 compared to N1 
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of non-rapid eye movement sleep (El-Chami et al., 2015).  The presence of hypocapnia at the 
onset of subsequent events may have also contributed to prolonging event duration; since 
additional time would be required to reach a level of carbon dioxide that was sufficient to 
terminate events in N2 compared to N1.   
Mechanisms responsible for the increase in event frequency and duration in the morning 
compared to the evening  
We previously reported that the frequency of events increased in the morning compared 
to the evening and afternoon in N1 (El-Chami et al., 2015).  This difference was also evident in a 
subgroup of participants (n = 5) during N2 (El-Chami et al., 2015).  As shown in the present 
investigation (see Figure 15) and in our previously published work (El-Chami et al., 2015) the 
duration of breathing events increased in the morning compared to the evening independent of 
the stage of non-rapid eye movement sleep.   
The increase in event duration in the morning compared to the evening in both N1 and 
N2 suggest that the arousal threshold along with the effective recruitment threshold of the upper 
airway muscles following airway collapse was higher in the morning compared to the evening.  
This suggestion is supported by previous results which showed that the respiratory effort 
immediately prior to termination of an event in N2 was increased in the morning compared to the 
evening, while the rate of change in respiratory effort during breathing events was not altered by 
the time of day (Cala et al., 1996;Montserrat et al., 1996b).  We also found that the rate of 
change of respiratory effort was similar during events within N1 and N2 in the evening and 
morning.  However, in contrast to previously published findings (Cala et al., 1996;Montserrat et 
al., 1996b) we found that the maximum respiratory effort at the termination of events was similar 
in the evening and morning within N1 and N2.  Thus, alterations in the arousal threshold or the 
sensitivity of the respiratory response to afferent inputs during events may not provide the sole 
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explanation for increases in event duration in the morning compared to the evening.  We propose 
that modulation of the carbon dioxide reserve, coupled to differences in metabolic rate linked to 
the time of day contribute to the prolongation of event duration in the morning.   
Earlier we showed that an increase in chemoreflex sensitivity coupled to a reduction in 
the carbon dioxide reserve was evident in the morning compared to the evening (El-Chami et al., 
2014b).  The increase in chemoreflex sensitivity likely contributed to the increase in tidal volume 
and the decrease in the partial pressure of end-tidal carbon dioxide that was evident in the 
morning compared to the evening within N1 or N2 in the present investigation.  Moreover, the 
increase in chemoreflex sensitivity coupled to a decrease in the carbon dioxide reserve in the 
morning likely ensured that the level of hypocapnia relative to the apneic threshold was greater 
at the onset of an event in the morning compared to evening.  Indeed, measures of end-tidal 
carbon dioxide immediately following event termination in the present investigation, coupled to 
previously published measures of the apneic threshold (El-Chami et al., 2014b), showed that the 
partial pressure of carbon dioxide in response to hyperventilation in the morning dropped below 
the apneic threshold but remained above it in the evening.  Given that studies have shown that 
the response to hypoxia is blunted or absent in the presence of hypocapnia (Rapanos & Duffin, 
1997b;Weil et al., 1970b;Wilson & Day, 2013b), it is possible that hypoxia does not significantly 
enhance receptor feedback prior to the abolition of hypocapnia, despite enhanced chemoreflex 
sensitivity. In addition, activation of chemoreflex inputs was likely reduced by a decrease in 
metabolic rate in the morning.  We have shown that core body temperature, minute ventilation 
and end tidal carbon dioxide are reduced in the morning compared to the evening (El-Chami et 
al., 2014b).  In addition, in the present study decreases in oxygen saturation were similar in the 
morning compared to the evening even though event duration was longer in the morning 
compared to the evening.  Thus, the presence of hypocapnia at the onset of events coupled with 
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the reduced metabolic rate in the morning could delay the stimuli (i.e. hypoxia and hypercapnia) 
required to activate the arousal and effective recruitment threshold, resulting in an increased 
event duration.  Likewise, the increased probability of carbon dioxide levels being less than 
values that demarcate the apneic threshold would likely contribute to increasing the frequency of 
apneic events (Dempsey et al., 2010;Mateika & Narwani, 2009;Mateika & Syed, 2013b). 
Conclusion 
We conclude that alterations in the arousal threshold, reflected by an increase in 
respiratory effort at event termination, coupled to increases in tidal volume and reductions in 
PETCO2 contribute to modifications in event duration and frequency associated with variations in 
sleep state or time of night. 
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CHAPTER 5 - MILD INTERMITTENT HYPOXIA WITH SUSTAINED 
HYPERCAPNIA REDUCES THERAPEUTIC CPAP AND IMPROVES AIRFLOW IN 
PARTICIPANTS WITH OBSTRUCTIVE SLEEP APNEA 
Introduction 
Long-term facilitation is characterized by a sustained increase in respiratory motor 
activity following exposure to mild intermittent hypoxia (Mateika and Syed, 2013).  A sustained 
increase in motor activity has been recorded at sites within the medulla and spinal cord that 
control ventilation and at sites in the medulla responsible for the control of upper airway muscles 
(Mateika and Fregosi, 1997; Babcock and Badr, 1998; Trumbower et al. 2012).  Long-term 
facilitation of phrenic motor nerve activity and ventilation has been initiated in a variety of 
species including healthy humans, humans with sleep apnea and spinal cord injured humans 
(Aboubakr et al., 2001; Fuller et al., 2003, Wadhwa et al., 2008; Devinney et al. ,2013; Tester et 
al. 2014).  Likewise, long-term facilitation of the hypoglossal nerve or the genioglossus muscle 
has been observed in a number of animals including humans (Fuller et al., 2001; Fuller, 2005; 
Chowdhuri et al., 2008; McKay et al., 2004).  Given that long-term facilitation of upper airway 
muscle activity can be initiated by intermittent hypoxia we and others hypothesized that the 
initiation of this phenomenon might improve upper airway patency in humans with sleep apnea 
(Mateika and Fregosi, 1997; Babcock and Badr, 1998; Aboubakr et al., 2001).  This led to the 
possibility that apnea severity across the night might improve as a consequence of natural 
exposure to intermittent hypoxia.  However, a number of studies have revealed that apnea 
severity increases rather than decreases from evening to morning (Fanfulla et al. 1997; Cala et 
al, .1996; Sforza et al., 1998).  We have addressed the potential reasons for the lack of influence 
of long-term facilitation on apnea severity in previous reviews (Mateika and Syed, 2013 ; 
Mateika et al., 2015 ; Mateika and Komnenov, 2016).  Briefly there are a variety of mechanisms 
(i.e. chemoreflex sensitivity, carbon dioxide reserve, airway inflammation) that are modulated 
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across the night that likely prevent or predominate over the influence potentially exerted by long-
term facilitation of upper airway muscle activity on airway collapsibility.  Consequently, we 
postulated that if these detrimental influences were minimized or eliminated then the effects of 
long-term facilitation might manifest more clearly.  More specifically we reasoned that improved 
upper airway patency via the initiation of long-term facilitation could potentially serve to reduce 
the positive airway pressure required to treat individuals with sleep apnea.  This reduced pressure 
could improve treatment compliance, which is reportedly limited (Sawyer et al., 2011), and 
ultimately the co-morbidities (i.e. cardiovascular, metabolic and neurocognitive) linked to sleep 
apnea.  This possibility coupled to the direct effects of intermittent hypoxia on these co-
morbidities that have been reported could serve as novel adjunct therapy to treat sleep apnea and 
its multiple co-morbidities.  Thus, the present investigation was designed primarily to determine 
if long-term facilitation of upper airway muscle activity initiated by exposure to intermittent 
hypoxia serves to reduce the therapeutic positive airway pressure required to maintain airway 
patency in individuals with obstructive sleep apnea.  
Long-term facilitation is mediated by at least two cellular pathways deemed the Q and S 
pathway (DeVinney et al., 2013).  It is has been hypothesized that the Q pathway is initiated by 
mild intermittent hypoxia.  This pathway is regulated in part by serotonin in addition to other 
neuromodulators.  Serotonin along with the proteins and kinases that have been identified within 
the Q pathway are reportedly modulated by a circadian rhythm (Agren et al., 1986, Mateos et al., 
2009, Sun et al., 2002, Serchov and Heumann, 2006).  If so, then the magnitude of long-term 
facilitation would be expected to vary according to the time of day. Indeed we previously 
reported that the magnitude of long-term facilitation of ventilation in humans was greater in the 
evening compared to the morning (Gerst et al., 2011).  Thus, a secondary aim of this 
investigation was designed to determine if the impact of long-term facilitation on the therapeutic 
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positive pressure required to treat obstructive sleep apnea was modulated by the time of day.   
Methods 
Protocol 
The Human Investigation Committees of Wayne State University School of Medicine 
and John D. Dingell Veterans Affairs Medical Center approved the experimental protocol.  Ten 
male participants completed the protocol by visiting the laboratory on six different occasions 
(Figure 17).  On the first visit, informed consent was obtained from participants before 
completion of a physical examination and health and lifestyle questionnaires.  In addition, blood 
pressure, lung volumes and a 12-lead ECG were obtained to confirm the absence of 
comorbidities (i.e. heart and lung disease, hypertension, and obesity).  During the second visit, 
participants completed a diagnostic nocturnal polysomnogram to determine the presence of 
obstructive sleep apnea.  Once confirmed participants maintained a regular sleep cycle at home 
for a two week period to ensure a consistent circadian rhythm.  Sleep/wake times were monitored 
via an actigraph watch (Actiwatch Spectrum, Philips Respironics, Murraysville, PA).  During 
this two week period, participants returned to the laboratory for an overnight visit (i.e. visit 3) to 
acclimate to continuous positive airway pressure ventilation and to determine the therapeutic 
pressure required to eliminate breathing events. 
 
Figure 17. A schematic diagram showing the protocol completed by the participants. * Sham 
protocol was conducted in the evening and morning only. † Administration of IH was 
randomized to evening or morning 
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After the two week period, participants returned for a 4th visit to complete a 21-hour 
constant routine protocol (Figure 17).  Participants arrived at the laboratory at 8 pm and 
completed 3 separate sleep sessions from 10 pm to 1 am, 6 am to 9 am and 2 pm to 5 pm.  
During each session the therapeutic continuous positive pressure airway pressure was 
established. Thereafter a sham protocol, emulating the timeline of the intermittent hypoxia 
intervention applied in visits 5 and 6 (see below for further for details), was completed.  During 
this time interval the partial pressure of end-tidal oxygen and carbon dioxide remained unaltered.   
Following completion of the protocol the continuous positive airway pressure was reduced in 1-2 
cmH2O decrements to compare measures of respiratory parameters (see Data Analysis for details 
of respiratory parameters) at similar pressures following exposure to intermittent hypoxia and 
sustained hypercapnia.  
During the 5 hours between sessions, participants were awake and in a semi-recumbent 
position.  The room was dimly lit with a luminance of 30 lux, while the temperature and 
humidity were maintained between 22-24° C and 25-35%, respectively.  The participants 
watched a movie (i.e. non-stimulating light comedies or documentaries) for two hours, followed 
by 90 minutes of reading, and 30 to 45 minutes of inactivity prior to the start of the setup for the 
following sleep session.  The subjects received small snacks with a constant caloric content 
every 95 minutes (composition: 75 % carbohydrates, 15% protein and 10% fat) and a maximum 
of 1L of water.  During completion of the protocol participants were isolated from external cues 
such as sunlight, TV, clocks, phones, computers, radios, and internet. 
During visits 5 and 6 the therapeutic pressure for a given sleep session was established 
and baseline (i.e. B1) measures of respiratory parameters (see Data Analysis for respiratory 
parameters measured) were obtained over a minimum of 10 minutes (Figure 18).  The partial 
pressure of end-tidal  carbon  dioxide (PETCO2)  was then increased by 3 mmHg and measures of  
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Figure 18. Diagram showing the severity and pattern of intermittent hypoxia. The tracings 
illustrates the changes in the partial pressure of end-tidal oxygen (PETO2) (upper) and carbon 
dioxide (PETCO2) (middle) and the alterations in continuous positive airway pressure throughout 
the protocol (bottom) 
the respiratory parameters were obtained for an additional 10 minutes during the second baseline 
(B2) period (Figure 18).  Thereafter, participants inspired a gas mixture comprised of 8 % oxygen 
and balance nitrogen to achieve a partial pressure of end-tidal oxygen (PETO2) (~ 55 mmHg) that 
resulted in an oxygen saturation of 88 % (Figure 20).  Maintenance of the PETO2 was achieved by 
the addition of 100 % oxygen into the circuit using a flowmeter.  Participants were exposed to 
this gas mixture 12 times for two-minutes each time.  The 12 hypoxic episodes were separated 
by 2 minute recovery intervals with the exception of the recovery period that followed the 12th 
hypoxic episode, which was 15 minutes in duration.  For presentation purposes the 15 minute 
recovery period was divided into three 5 minute segments.  Throughout the protocol, including 
the end recovery period, the PETCO2 was maintained at 3 mmHg above baseline (Figure 18).  
After the 15 minute end-recovery period the continuous positive airway pressure was reduced in 
1-2 cmH2O steps.  The participants were exposed to the IH and sustained hypercapnia during an 
evening (10 pm to 1 am) and morning session (6 am to 9 am) on separate occasions (Visits 5 and 
20 min
PETCO2
10 min  
3 mmHg
50 mmHg
PETO2
10 min   2 min
1‐2 cmH2O
Baseline continuous 
positive airway pressure
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6), which were randomized.  When the participants were exposed to IH and sustained 
hypercapnia in the morning they were treated with continuous positive airway during the evening 
session without exposure to the hypoxic stimulus. 
Instrumentation 
During the sleep studies the monitoring montage included an electroencephalogram 
(C3/A2, C4/A1, O1/A2, O2/A1), electrooculograms, submental electromyogram, and an 
electrocardiogram.  Chest wall and abdominal movements were measured using inductive 
plethysmography (Respitrace, Ambulatory Monitoring, Ardsley, NY).  Airflow and breath 
timing (inspiratory and expiratory time) were measured using a pneumotachometer (model 
RSS100-HR, Hans Rudolph, Shawnee, KS) attached to a nasal mask.  Oxygen saturation (arterial 
O2 saturation) was measured with a pulse oximeter (Biox 3700; Ohmeda, Boulder, CO). 
Measures of end-tidal oxygen (Model 17515, Vacumed, Ventura, CA) and carbon dioxide 
(Model 17518, Vacumed, Ventura, CA) were obtained from air expired into sampling tubes 
attached to ports on the nasal mask.  Nasal pressure was measured using a pressure transducer 
attached via tubing to a port on the nasal mask.  Upper airway pressure was measured using a 
transducer tipped catheter (Mikro-Cath 825-0101, Millar, Houston, TX) to confirm apnea and 
ascertain the presence of flow limitation.  All physiological variables were analog to digitally 
converted at a sampling frequency of 100 Hz/channel and input into a computer using a 
commercially available software package (gamma version 4.0, Astro-Med, West Warwick, RI).  
The cardiorespiratory variables were also input into a second computer using a commercially 
available software package (WinDaq, Dataq Instruments, Akron, OH). 
Data analysis 
Nocturnal polysomnography.  All polysomnography studies were analyzed in 30s epochs 
for sleep stage and arousals.  In addition, during the second visit respiratory-related events were 
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scored according to standard published criteria.  Apneas were defined as the cessation of 
inspiratory flow for 10 seconds or more, while hypopneas were characterized by a decrease in 
inspiratory flow of more than 50% accompanied by a 3% (or greater) blood oxygen desaturation 
and/or an arousal from sleep.  The apnea hypopnea index (i.e. the average number of respiratory 
events per hour) was determined to ensure that the severity of sleep apnea fell within the 
inclusion criteria. 
Intermittent hypoxia protocol.  The physiological parameters measured throughout the 
protocol were ventilation, PETCO2, PETO2, SaO2, heart rate, tidal volume and breathing 
frequency.  Average absolute values of the parameters were obtained from the last 2 minutes of 
B1, B2, the last minute of each hypoxic and recovery period and the last two minutes of each 
decrement in continuous positive airway pressure. Select data were standardized to B2 to 
compare results between the intermittent hypoxia and sham protocol.  This analysis was 
completed because measures of minute ventilation and tidal volume were greater during B2 of 
the intermittent hypoxia compared to the sham protocol because PETCO2 was increased 3 mmHg 
above baseline during B2 of the intermittent hypoxia protocol.  Average values of tidal volume, 
airflow and upper airway resistance were determined from 10 breaths measured during the last 
minute of B2.  Data from the last minute of end recovery and from two step downs were 
standardized to B2 measures.  The selected step downs in pressure were equivalent to values of 
positive pressure that resulted in a 25 % and 50 % reduction in airflow during the sham protocol.  
Resistance was defined as the inverse of the average slope of the linear portion in the 
pressure/flow loop (Figure 19). In order to obtain the slope, commercial software (Matlab) was 
used to calculate the slope of a series of 3 sequential data points measured during inspiration 
prior to a plateau in airflow (Figure 19).  The slopes were then averaged for each breath.  
Thereafter a 10 breath average was calculated for each selected period outlined above.  
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Figure 19. Figure showing the method used to measure upper airway resistance. A tangent line 
was fit to 3 consecutive points throughout the inspiratory portion of the breath prior to maximal 
flow to determine resistance (1/slope of the tangent line). 
Sham protocol.  The sham protocol was completed to compare the changes (or lack 
thereof) in the physiological parameters following exposure to the continuous positive airway 
pressure for a duration comparable to the one required to complete the intermittent hypoxia 
protocol.  The comparison serves to ensure that the hypothesized improvement in upper airway 
and breathing stability were due to intermittent hypoxia and sustained hypercapnia.  Analysis of 
the data measured during the sham protocols was identical to the analysis completed for the 
intermittent hypoxia trials (see explanation above).  
Statistical analysis 
A two way analysis of variance with repeated measures in conjunction with Student 
Newman Keuls post hoc test was used to compare data measured during B2 of the intermittent 
and sham protocol.  The factors in the design were “protocol” (intermittent hypoxia vs. sham) 
and “time of day” (evening vs. morning).  A similar analysis was used to compare the data 
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within a given protocol (i.e. intermittent hypoxia or sham).  The factors in the design were “time 
point” (B2 vs. End Recovery 1, 2 & 3 vs. Step Down 1, 2, 3 & 4) and “time of day” (evening vs. 
morning).  Lastly, this analysis was used to compare the standardized data across the intermittent 
hypoxia and sham protocols.  The factors in the design were “time point” (B2 vs. End Recovery 
vs. Step Down 25 % & 50 %) and “time of day” (evening vs. morning). Data are presented as 
means ± SE. P ≤ 0.05 was considered statistically significant.  0.05 < P ≤ 0.07 was considered to 
be characteristic of a trend toward significance. 
Results 
Table 5 shows the anthropometric variables obtained for the group.  Collectively, the 
participants were young to middle age, and not obese, as indicated by the body mass index. The 
apnea/hypopnea index determined from the screening sleep study (i.e., Visit 2) ranged from mild 
to severe according to standard criteria.  The level of oxygen desaturation achieved during 
apneic/hypopneic events was mild even in those participants considered to have severe sleep 
apnea.  Systolic and diastolic blood pressure measurements were within normal limits and the 
Epworth sleepiness scale indicated a history of mild sleepiness.  The average therapeutic 
pressure required to eliminate apnea during sleep on visit 3 in the obstructive sleep apnea 
participants was 11 ± 0.7 cmH2O.  
Table 5. Baseline anthropometric, blood pressure and sleep measures 
Variable  
Age, yr. 25.2 ± 2.2 
Height, cm 178.3 ± 5.5 
Weight, kg 83.6 ± 3.1 
Body mass index, kg/m2 25.7 ± 0.9 
Systolic pressure, mmHg 120.1 ± 3.2 
Diastolic pressure, mmHg 72.2 ± 3.3 
Epworth Sleepiness Scale 8.3 ± 1.4 
Apnea/hypopnea index, events/hr 37.03 ± 5.2 
Lowest oxygen desaturation during apnea, % 88.8 ± 1.4 
Race 7 Caucasian ,2 AA , 1 Indian 
Values are means ± SE 
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The therapeutic pressure required to eliminate apnea during B2 of the sham protocol in 
the evening and the morning was 11.2 ± 0.6 and 12.4 ± 0.5 cmH2O, respectively.  The 
therapeutic pressure required to eliminate apnea during B2 of the intermittent hypoxia protocol in 
the evening and the morning was 12.1 ± 0.7 and 13.1 ± 0.7 cmH2O, respectively.  The 
therapeutic pressure required to eliminate apnea was significantly less in the evening compared 
to the morning during the intermittent hypoxia and sham protocol (P < 0.02).  The therapeutic 
pressure during B2 of the intermittent hypoxia protocol tended to be increased compared to the 
therapeutic pressure measured at the same time point during the sham protocols in the evening 
and morning (P < 0.06).  
Measures of the physiological parameters obtained during B1 and B2 of the sham and 
intermittent hypoxia protocols are shown in Figure 20.  Note that by design PETCO2 during B2 
was greater during the intermittent hypoxia compared to the sham protocols (P < 0.005).  
Consequently, minute ventilation (P < 0.001) and tidal volume (P < 0.001) were greater during 
B2 of the intermittent hypoxia compared to the sham protocols.   
Following exposure to intermittent hypoxia minute ventilation (P < 0.001) and tidal 
volume (P < 0.001) during end-recovery and the step-downs in positive pressure were greater 
compared to B2 (P < 0.001) (Figure 20).  Consequently, PETO2 was greater during the end-
recovery period following exposure to intermittent hypoxia compared to B2 (P < 0.01) (Figure 
20).  The increases observed following exposure to intermittent hypoxia were evident even 
though the therapeutic pressure (P = 0.4) and PETCO2 (P = 0.3) during the end-recovery periods 
were similar to measures obtained during B2.  The increase in minute ventilation tended to be 
greater (P = 0.07) and the increase in tidal volume was greater (P = 0.04) in the evening 
compared to the morning (Figure 20).  Following exposure to the sham protocol minute 
ventilation (P > 0.7) and tidal volume (P > 0.3) during end–recovery and the step-downs in 
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positive pressure were similar to B2.  
 
Figure 20. Scatter plots showing changes in end-tidal PETCO2, PETO2, minute ventilation, tidal 
volume,  blood oxygen saturation (SaO2), breathing frequency, and continuous positive airway 
pressure throughout the intermittent hypoxia and sham protocols. *significantly different than 
baseline ; ‡significantly different than the evening. 
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As expected the increase in tidal volume observed during the end recovery period was 
coupled to an increase in inspiratory flow following exposure to intermittent hypoxia (P < 0.003) 
but not after the sham protocol (Figure 21).  Likewise, airway resistance during the end recovery 
period was significantly reduced following exposure to intermittent hypoxia compared to the 
sham protocols (P < 0.03).  The increase in inspiratory flow and the decrease in resistance 
following exposure to intermittent hypoxia during the end recovery period were similar in the 
evening and the morning.  Inspiratory flow and resistance remained at baseline levels following 
exposure to intermittent hypoxia after the therapeutic positive airway pressure was reduced by 5 
cm H2O (Figure 21).  In contrast, after completion of the sham protocol inspiratory flow was 
reduced (P < 0.001) and resistance was increased (P < 0.01) in response to the 5 cm H2O 
reduction in positive airway pressure (Figure 21).  After the positive airway pressure was 
reduced by 7 cm H2O following exposure to intermittent hypoxia, inspiratory flow was reduced 
and resistance was greater compared to baseline in some participants but not others. 
Consequently, these measures were not significantly different from baseline.  In contrast, 
inspiratory flow was reduced and resistance were greater than baseline following the sham 
protocol (P < 0.04) (Figure 21).  The changes in inspiratory flow after the 5 and 7 cm H2O 
reduction in positive airway pressure during recovery from the intermittent hypoxia and sham 
protocols were similar in the evening and morning (Figure 21).  In contrast, resistance measures 
were greater in the morning compared to the evening after the positive airway pressure was 
reduced by 5 and 7 cm H2O following the sham protocol (see 5 and 7 cm H2O) (P < 0.02) 
(Figure 21).  
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Figure 21. Histograms showing airflow (top) and upper airway resistance (bottom) after 
completion of the intermittent hypoxia or sham protocols. Measures were obtained at baseline 
therapeutic pressure and following decreases in pressure that corresponded to a 25 and 50% 
decrease in airflow during the sham protocol. Note that despite the decrease in pressure, flow and 
resistance were not significantly altered compared to baseline and the sham protocols. 
*significantly different than baseline; †significantly different than sham; ‡significantly different 
than the evening. 
Baseline resistance values in cmH2O/L/s
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Discussion 
We confirmed our previous findings that exposure to mild intermittent hypoxia initiates 
long-term facilitation of minute ventilation during sleep in individuals treated with continuous 
positive airway pressure.  Novel findings from our investigation indicated that exposure to mild 
intermittent hypoxia initiates long-term facilitation of upper airway muscle activity.  The 
initiation of this phenomenon was reflected by an increase in airflow and a reduction in airway 
resistance during treatment with positive airway pressure following exposure to intermittent 
hypoxia.  Moreover, airflow and airway resistance were maintained at baseline levels even after 
positive airway pressure was reduced below therapeutic values.  In addition to our primary 
findings, our secondary findings revealed that upper airway patency could be modulated by a 
circadian rhythm, which supports our previous findings.  More specifically the therapeutic 
pressure required to maintain airway patency was higher in the morning compared to the evening 
during completion of the sham protocols.  Likewise, a reduction in positive airway pressure 
below therapeutic values (i.e. 7 cm H2O) resulted in an increase in airway resistance which was 
greater in magnitude in the morning compared to the evening.   
Critique of experimental protocol 
In the present investigation mild intermittent hypoxia was used to initiate respiratory 
plasticity.  The use of intermittent hypoxia as a therapeutic modality is counterintuitive to the 
findings from a number of animal studies which suggested that intermittent hypoxia causes 
autonomic, metabolic and neurocognitive dysfunction (Fletcher 1995, 1997, 2000 and 2001).  
However, to our knowledge there is little to no evidence that mild intermittent hypoxia leads to 
these detrimental outcomes which have been linked to long-term exposure to severe levels of 
hypoxia.  Instead, a number of reviews, with the support of published research findings, have 
convincingly outlined that numerous beneficial outcomes might be linked to exposure to mild 
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intermittent hypoxia (Mateika et al.,2015; Mateika and Komnenov, 2016; Serebrovskaya et al., 
2008).  However, we did report previously that some forms of respiratory plasticity (i.e. 
progressive augmentation) initiated by acute exposure to mild intermittent hypoxia promotes 
breathing instability particularly when other forms of plasticity that could be beneficial (i.e. long-
term facilitation) are neutralized (Yokhana et al., 2012).  Therefore we proposed that the 
potential beneficial effects of long-term facilitation might only manifest if the detrimental forms 
of plasticity are eliminated or mitigated.  Thus we proposed that the beneficial effects of long-
term facilitation will be clearly evident once the influence of progressive augmentation was 
mitigated or eliminated with continuous positive airway pressure.   
In our investigation intermittent hypoxia was combined with a level of carbon dioxide 
that was sustained slightly above baseline levels.  The maintenance of carbon dioxide throughout 
the intermittent hypoxia protocol was employed to ensure that long-term facilitation of 
ventilation clearly manifested itself throughout the protocol; since we previously established that 
long-term facilitation typically does not manifest in the presence of hypocapnia (Mateika and 
Sandhu, 2011).  Given the employment of carbon dioxide levels that were above baseline it 
could be argued that the long-term facilitation that was evident, and coupled to reduced upper 
airway resistance and collapsibility, was induced principally by forms of respiratory induced by 
increased levels of carbon dioxide.  However, we previously completed control experiments 
which showed that the magnitude of long-term facilitation of ventilation was determined wholly 
or principally by exposure to intermittent hypoxia and not sustained hypercapnia (Harris et al., 
2006).  Moreover, we showed that repeated daily exposure to elevated levels of carbon dioxide 
did not lead to long-term facilitation of minute ventilation.  In contrast, repeated daily exposure 
to intermittent hypoxia led to a progressive increase in the magnitude of long-term facilitation. 
It has been standard practice to measure airway resistance as the inverse of the slope at a 
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specific point on the linear portion of the flow-pressure curve.  However, given the complex 
dynamic nature of the airway during inspiration the customary method neglects the progression 
of airway mechanics and thus measures only reflect the initial portion of inspiration.  Therefore 
airway resistance at points closer to termination of inspiration is not reflected in the 
measurement.  The method we used reflects the average resistance measured throughout the 
inspiratory phase prior to a plateau in inspiratory flow.  It is reasonable to suggest that the 
method we employed does not control for the potential impact of a number of variables that 
might influence airway resistance (e.g. lung volume).  Although this is a viable argument, 
measuring upper airway resistance throughout inspiration accurately reflects the impact of long-
term facilitation on this variable.    
Long-term facilitation of minute ventilation and its components 
The results from the present study largely confirm our previous findings that exposure to 
mild intermittent hypoxia induces long-term facilitation of minute ventilation during sleep.  
Likewise, our results confirm that modulation of tidal volume was principally responsible for the 
observed long-term facilitation.  We were also interested in examining if long-term facilitation of 
minute ventilation was modulated by the time of day.  Previously we reported that the magnitude 
of long-term facilitation during wakefulness was greater in the evening compared to the morning 
in humans with obstructive sleep apnea.  The mechanisms responsible for the diurnal variation in 
ventilatory long-term facilitation remain to be determined.  However, one intriguing possibility is 
that evening to morning alterations in serotonin levels are responsible for our observations.  
Serotonin is a neuromodulator required for the initiation of ventilatory long-term facilitation in 
rats.  Moreover, serotonergic levels vary between wakefulness and sleep, with levels being 
higher during the former state.  More importantly, the synthesis and release of serotonin via 
adrenergic signaling in rats have been reported under constant lighting conditions, with peak 
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levels occurring later in the day and decreased synthesis and release in the early morning.  
Similar to the previous findings obtained during wakefulness we did observe differences in the 
magnitude of long-term facilitation of minute ventilation and tidal volume in the evening 
compared to the morning during sleep; although the magnitude of the difference was less during 
sleep compared to wakefulness.  The reason for this discrepant finding remains to be determined.  
It is possible that the modulation of serotonin from the evening to the morning during sleep is not 
as great compared to the ‘awake’ state.  Alternatively, it is possible that the modulation from 
evening to morning is significant enough to initiate differences but that the end-recovery time 
employed in the present investigation was not sufficient to allow clear differences in magnitude 
to manifest.  More specifically it has been shown in animals including humans that long-term 
facilitation tends to “wind-up” during the recovery period following exposure to intermittent 
hypoxia.  Typically this “wind-up” does not occur immediately at the onset of the recovery 
period.  Consequently, because the end-recovery period was relatively short while the 
participants were treated with therapeutic continuous positive airway pressure clear differences 
in the magnitude of long-term facilitation between the evening and the morning might not have 
manifested.  This is a possibility given that evening to morning differences appeared to manifest 
in measures of upper airway resistance (see below for additional details).  
Impact of long-term facilitation on therapeutic positive airway pressure  
As expected long-term facilitation of minute ventilation was accompanied by an increase 
in inspiratory flow during end recovery following exposure to intermittent hypoxia while the 
participants were treated with therapeutic continuous positive airway pressure.  In contrast, 
airflow remained at baseline levels following exposure to the sham protocols.  The increase in 
inspiratory flow could be the consequence of initiating long-term facilitation of upper airway 
and/or phrenic motoneurons.  In regards to the testing of our primary hypothesis (see 
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Introduction) we were interested in establishing if long-term facilitation of upper airway muscle 
activity was initiated following exposure to intermittent hypoxia.  To support this possibility we 
examined changes in upper airway resistance after exposure to intermittent hypoxia.  Moreover, 
we determined if the upper airway was less collapsible by examining inspiratory airflow patterns 
following reductions in positive airway pressure.  Our results showed that in addition to 
increases in inspiratory flow, upper airway resistance was reduced compared to baseline 
following exposure to intermittent hypoxia when the participants were treated with therapeutic 
continuous positive airway pressure.  This finding is similar to the results reported by Rowley 
and colleagues.  In contrast, upper airway resistance remained at baseline levels following 
exposure to the sham protocol.  Moreover, when the positive airway pressure was reduced by 5 
cmH2O inspiratory airflow and resistance remained unaffected following exposure to intermittent 
hypoxia.  These findings suggest that both upper airway collapsibility and resistance are 
impacted by exposure to mild intermittent hypoxia.  Our results are in contrast to the findings of 
Rowley and colleagues who reported that upper airway collapsibility remained unaltered despite 
decreases in upper airway resistance following exposure to intermittent hypoxia (Rowley et al., 
2007).  We also showed that inspiratory airflow was limited and upper airway resistance 
increased when the positive airway pressure was reduced by 5 cm H2O following exposure to the 
sham protocol.  Similarly although reductions in flow and increases in upper airway resistance 
were evident after the positive airway pressure was reduced by 7 cm H2O following exposure to 
intermittent hypoxia the changes observed far exceeded the modifications in inspiratory flow and 
upper airway resistance when the positive airway pressure was reduced by a similar amount after 
exposure to the sham protocol.      
The inspiratory flow modifications observed during end recovery in response to treatment 
with the therapeutic pressure or thereafter when the positive airway pressure was reduced were 
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similar in the evening compared to the morning.  This findings suggests the magnitude of long-
term facilitation of upper airway muscle activity or lack thereof (i.e. sham protocol) was not 
modulated by the time of day.  Alternatively, increases in upper airway resistance were greater in 
the morning compared to the evening when the positive airway pressure was reduced by 5 and 7 
cm H2O following the sham protocol, indicating the possibility that long-term facilitation might 
be modulated by time of day.    
The inspiratory airflow patterns observed following the sham protocol also indicated that 
time of day had no impact on upper airway collapsibility.  This latter finding does not support 
our previous results which showed that collapsibility of the upper airway was greater in the 
morning compared to the evening.  Likewise, it is counter to findings from the present study 
which showed that the therapeutic pressure required to eliminate apneic events was greater in the 
morning compared to the evening although admittedly the differences were not dramatic.  Lastly, 
following the sham protocol upper airway resistance was greater in the morning compared to the 
evening after the positive airway pressure was reduced by 5 and 7 cm H2O.  Thus, the 
preponderance of evidence suggests that factors influencing upper airway resistance and 
collapsibility are likely impacted by the time of day.  
Summary and conclusions  
We have shown that exposure to mild intermittent hypoxia leads to the initiation of forms 
of respiratory plasticity that are beneficial to improving upper airway patency.  More specifically 
we showed that following exposure to intermittent hypoxia continuous positive airway pressure 
could be reduced by 5 cm H2O without impacting on inspiratory airflow and upper airway 
resistance.  We propose that exposure to intermittent hypoxia might serve as an adjunct therapy 
to promote airway patency, which in turn could reduce the therapeutic pressure required to treat 
sleep apnea and potentially improve treatment compliance leading to improved outcome 
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measures.  Likewise we propose that in addition to improving compliance mild intermittent 
hypoxia might have a direct impact on a number of co-morbid conditions associated with sleep 
apnea.  Thus mild intermittent hypoxia could serve as a multi-pronged therapy to mitigate co-
morbidities associated with sleep apnea both directly and indirectly by improving treatment 
compliance.    
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CHAPTER 6 - CONCLUSION 
We have shown in the 2 aims discussed throughout this dissertation that multiple 
mechanisms involved in the control of breathing are indeed modulated in a circadian fashion, 
resulting in increased sensitivity to blood gas fluctuations, decreased carbon dioxide reserve and 
increased airway collapsibility.  Those patterns were tightly correlated to with baseline carbon 
dioxide levels, potentially connecting them to a plethora of metabolic and hormonal changes.  
The subsequent breathing instability was evident in the observation that breathing events were 
longer in duration in N1 and N2 stages of sleep, and more frequent in the N1 stage.  Such 
manifestation of the abovementioned patterns would have an impact on the treatment of 
obstructive sleep apnea with continuous positive airway pressure, as well as the recommended 
sleep scheduling and daytime naps.  In addition, the therapeutic pressure required to eliminate 
one's breathing events will be largely affected.  Titrations are therefore often overestimating the 
pressure for evening and afternoon sleep and/or underestimating it for morning sleep.  Another 
therapeutic benefit from these findings is the identification of the increased collapsibility and 
chemoreflex sensitivity as potential pharmaceutical targets to mitigate the severity of OSA. 
Given that a multitude of the discussed mechanisms is affected/modulated by serotonin, 
we then investigated a potential circadian variation of the initiation and magnitude of respiratory 
plasticity, in which serotonin is a key player.  We were mainly interested in the long term 
facilitation of upper airway muscle activity.  The focus on that form of plasticity was catalyzed 
by its importance in maintaining upper airway patency, and consequently affecting the TP. 
Using intermittent hypoxia as a stimulus, we successfully initiated LTF of upper airway 
muscles, as evident by the ability of the airway to maintain optimal airflow at lower pressures, as 
well as a lack of resistance to that airflow.  That effect was more maintainable in the evening 
compared to the morning (mainly in terms of developing resistance).  Such findings can have a 
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big impact on OSA and CPAP therapy, one that has been largely marred by a low compliance 
rate due to uncomfortably high pressures.  Initiating upper airway LTF and decreasing TP has the 
potential to revolutionize the approach to titration and CPAP prescription.  IH, as an adjunct 
treatment, could be computerized and incorporated into the CPAP technology, which, along with 
the available auto-PAP abilities, might combine for a much more efficient and accurate way to 
administer positive pressure hopefully leading to a higher compliance level and consequently 
mitigating the severity of disorders caused by sleep apnea. 
Finally, as we discussed in length in Chapter 5, IH in itself is garnering increasing 
support and evidence to its potential as a therapeutic modality, exerting both indirect and direct 
beneficial effects targeting many of the downstream co-morbidities of OSA, making it a multi-
pronged therapeutic approach very worthy of further examination. 
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Purpose:  Our project was designed to determine the effect of time of day on multiple 
mechanisms influencing breathing stability and respiratory plasticity.  We investigated if the 
number and duration of breathing events coupled to upper airway collapsibility, as well as the 
carbon dioxide reserve, chemoreflex sensitivity and arousal threshold during non-rapid eye 
movement (NREM) sleep were affected by the time of day.  In addition, we examined if mild 
intermittent hypoxia (IH) initiates long-term facilitation of upper airway muscle activity leading 
to a reduction in the therapeutic continuous positive airway pressure required to eliminate 
breathing events.  
Methods:  Male participants with obstructive sleep apnea completed a constant routine protocol 
that consisted of sleep sessions in the evening (10 PM to 1 AM), morning (6 AM to 9 AM), and 
afternoon (2 PM to 5 PM).  On one occasion the number and duration of breathing events was 
ascertained for each sleep session.  For breathing events detected during these sessions the rate of 
change of respiratory effort, maximum respiratory effort immediately prior to termination of an 
event, and the maximum tidal volume and the minimum partial pressure of end-tidal carbon 
dioxide (PETCO2) immediately following an event were measured.  Participants then completed 
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the same protocol on two additional occasions, where the critical closing pressure that 
demarcated upper airway collapsibility was determined on one, and baseline levels of carbon 
dioxide PET(CO2) and minute ventilation, as well as the PET(CO2) that demarcated the apneic 
threshold and hypocapnic ventilatory response were measured on the other (the order of these 2 
visits was randomized).  In the second aim of the study, male participants with obstructive sleep 
apnea were treated with twelve 2-minute episodes of hypoxia (PETO2 ≈ 50 mmHg) separated by 
2-minute intervals of normoxia in the presence of PETCO2 that was sustained 3 mmHg above 
baseline.  During recovery from the last episode the positive airway pressure was reduced in a 
step-wise fashion until flow limitation was evident.  The participants also completed a sham 
protocol under normocapnic conditions, which mimicked the timeframe of the IH protocol.   
Results:  The duration of breathing events was consistently greater in the morning compared 
with the evening and afternoon during N1 and N2, while an increase in event frequency was 
evident during N1.  The critical closing pressure was increased in the morning (2.68 ± 0.98 cm 
H2O) compared with the evening (1.29 ± 0.91 cm H2O; P ≤ 0.02) and afternoon (1.25 ± 0.79; P ≤ 
0.01).  The increase in the critical closing pressure was correlated to the decrease in the baseline 
partial pressure of carbon dioxide in the morning compared with the afternoon and evening (r = 
−0.73, P ≤ 0.005).   The nadir of core body temperature during sleep occurred in the morning and 
was accompanied by reductions in minute ventilation and PETCO2 compared with the evening 
and afternoon (minute ventilation: 5.3 ± 0.3 vs. 6.2 ± 0.2 vs. 6.1 ± 0.2 l/min, P < 0.02; PET(CO2): 
39.7 ± 0.4 vs. 41.4 ± 0.6 vs. 40.4 ± 0.6 Torr, P < 0.02).  The carbon dioxide reserve was reduced, 
and the hypocapnic ventilatory response increased in the morning compared with the evening 
and afternoon (carbon dioxide reserve: 2.1 ± 0.3 vs. 3.6 ± 0.5 vs. 3.5 ± 0.3 Torr, P < 0.002; 
hypocapnic ventilatory response: 2.3 ± 0.3 vs. 1.6 ± 0.2 vs. 1.8 ± 0.2 l·min(-1)·mmHg(-1), P < 
0.001).  The rate of change of respiratory effort was similar in N2 compared to N1 but the 
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maximum respiratory effort immediately prior to event termination was greater (-10.7 ± 1.2 vs. -
9.6 ± 1.0 cm H2O/s, P < 0.05).  Likewise, tidal volume was increased (1169 ± 105 vs. 1082 ± 
100 ml, P < 0.05) and PETCO2 was decreased (37.0 ± 0.8 vs. 37.7 ± 0.8 mmHg P < 0.05) 
following events in N2 compared to N1.  A similar tidal volume and PETCO2 response was 
evident following events in the morning compared to the evening independent of sleep stage.  
After exposure to IH the therapeutic pressure was significantly reduced (Δ CPAP = - 4.95 ± 0.5 
cmH2O, p < 0.001) without evidence of flow limitation (P > 0.2) or increases in upper airway 
resistance (P > 0.4).  In contrast, a similar decrease in pressure was accompanied by significant 
flow limitation (P < 0.003) and an increase in upper airway resistance (P < 0.01) following 
completion of the sham protocol. 
Conclusion:  Our findings indicate that time of day affects the duration and frequency of events, 
coupled with alterations in upper airway collapsibility and chemoreflex properties during sleep, 
which may contribute to increases in breathing instability in the morning compared with other 
periods throughout the day/night cycle in individuals with sleep apnea.  We propose that 
increases in airway collapsibility in the morning may be linked to an endogenous modulation of 
baseline carbon dioxide levels and chemoreflex sensitivity, which are independent of the 
consequences of sleep apnea.  We also conclude that alterations in the arousal threshold, 
reflected by an increase in respiratory effort at event termination, coupled to increases in tidal 
volume and reductions in PETCO2 contribute to modifications in event duration and frequency 
associated with variations in sleep state or time of night.  In addition, exposure to IH decreases 
the therapeutic pressure required to eliminate apneic events which could improve treatment 
compliance.  This possibility coupled with the direct beneficial effects of IH on co-morbidities 
linked to sleep apnea suggests that IH may have a multipronged therapeutic effect on sleep 
apnea.  
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